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ABSTRACT
The effects of a multiple step antioxidant nutritional supplementation
protocol on high-intensity cycling performance
Ryan Hobbs

PURPOSE: To determine if 5 days of antioxidant supplementation coupled with a preride antioxidant/energy supplement improves cycling performance or reduces oxidative
stress in trained cyclists.
METHODS: Eight well-trained cyclists participated in a double-blind cross-over
placebo-controlled study. Maximal oxygen consumption (VO2Max), peak power output
(WMax) and total work during a 15-minute time trial were determined. Subjects
consumed an antioxidant supplement (S) or a placebo (P) for 5 days before each trial and
a pre-exercise supplement or isocaloric placebo (4 kcal·kg-1) 45 minutes before each trial.
Subjects performed an endurance ride of 90 minutes followed immediately by a time trial
requiring accumulation of total work equal to the initial time trial.
RESULTS: The GSH:GSSG ratio remained constant prior to both experimental trials,
while resting total GSH concentrations exhibited a main effect (p = 0.038) in response to
step-one of the supplement protocol for basal (S: 1020.2 ± 135.8 µmol·L-1; P: 1000.2 ±
252.9 µmol·L-1) vs. pre-endurance (S: 979.2 ± 155.1 µmol·L-1; P: 867.3 ± 231.2 µmol·L1
). During the endurance ride, no differences were observed in average power (S: 224.0 ±
36.5 W; P: 219.1 ± 19.2 W), oxygen consumption (S: 2.8 ± 0.4 L·min-1; P: 2.8 ± 0.4
L·min-1), heart rate (S: 148.4 ± 3.5 beats·min-1; P: 146.3 ± 4.5 beats·min-1), or
GSH:GSSG ratio (S: 1.4 ± 0.7; P: 1.4 ± 0.9). During the time trial tests, supplementation
did not lead to any differences between average power (S: 303.6 ± 59.2 W; P: 306.1 ±
47.0 W), oxygen consumption (S: 3.5 ± 0.4 L·min-1; P: 3.3 ± 0.6 L·min-1), heart rate (S:
171.1 ± 6.5 beats·min-1; P: 170.3 ± 3.5 beats·min-1), or GSH:GSSG ratio (S: 1.1 ± 0.6; P:
0.9 ± 0.7).
CONCLUSION: Consuming an antioxidant supplement for 5 days coupled with a preexercise antioxidant/energy supplement does not result in significant improvements in
cycling performance. However, the multiple-step supplementation may attenuate
oxidative stress during the cycling bout when compared to a placebo, possibly due to the
maintenance of glutathione levels.
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Chapter 1. Introduction
1.1. Purpose & Specific Aims
1.1.1. Purpose
The ability to perform high intensity aerobic endurance activity requires a significant increase
in oxygen consumption (VO2) and is clearly demonstrated by the linear increase in VO2 which
occurs as intensity increases during a graded cycle ergometry test.81 In order to meet the work
demand, a constant supply of energy to the working muscles must be provided to maintain
performance during high intensity aerobic exercise.59, 72 These activities can result in
accumulation of reactive oxygen species,39 oxidative stress,64 and oxidative muscle damage42, 100
due to increased radical production associated with increased oxygen consumption.63 Recent
studies have examined the effect of various dietary supplements on their ability to enhance
endurance performance,81 alter fuel metabolism,36, 86 decrease markers of oxidative stress,82, 108
and decrease markers of post-exercise muscle damage.42, 97 These dietary supplements include
carbohydrate,59, 72 protein,79, 110, 122 arginine,1, 86 carnitine,12 aspartate,1 tartrate,12 vitamins A, C,
and E,2, 19, 20, 82, 93, 113 selenium,97, 118 allopurinol,42 Siberian ginseng,30 and reduced glutathione.108
Most of these supplements have required long-term (~ 4 weeks) use to provide the desired
effects,2, 20, 42, 81 and most have been studied independently of one another.19, 42, 86, 93, 118 It has
been suggested that because most of these supplements work synergistically, they should be
consumed in combination as an antioxidant energy substrate cocktail, rather than
independently.112 Thus, supplementation with antioxidant energy substrate cocktails has also
been evaluated in regards to providing ergogenic effects.81, 119
There is evidence that consumption of antioxidant energy substrate cocktails increase
endurance performance,81 but no underlying mechanisms have been identified. In addition,
recent research has suggested that long-term supplementation could be detrimental to cellular
1

adaptations that lead to improvements in endurance capacity.41 Thus, short-term antioxidant
supplementation could lead to improvements in performance without interrupting cellular
adaptations that occur as a result of training. Therefore, the purpose of this project was to
determine if a multiple step antioxidant nutritional supplement protocol which includes a 5 day
antioxidant cocktail loading phase coupled with a pre-event antioxidant/energy beverage
increases performance, reduces markers of oxidative stress, or enhances fuel metabolism during
a high-intensity cycle ergometry exercise test in trained competitive cyclists.
1.1.2. Central Hypothesis
This study examined the effects of a short-term multiple step antioxidant nutritional
supplement protocol in high-intensity cycling. The central hypothesis was that a multiple step
antioxidant nutritional supplement protocol would result in increased cycling performance via
enhancement of fuel metabolism and by reducing levels of oxidative stress. This central
hypothesis was tested by addressing the following four specific aims.
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1.1.3. Specific Aim 1
The first aim was to determine whether supplementation would alter cycling performance in
trained male cyclists when compared to a multiple step isocaloric placebo. The aim was
examined by determining the amount of time to achieve a pre-determined amount of work, the
average power output, and oxygen consumption during a validated repeated measure cycle
ergometry test (preload+time trial).
Hypothesis 1:
A multiple step antioxidant nutritional supplement protocol would result in a decreased
time to complete the set amount of work during the time trial, an increase in average
power output per given average heart rate and a decrease in relative oxygen consumption
per given power output during the cycle ergometry test at 30 min, 60 min, and 90 min of
the preload and throughout the time trial when compared with a placebo protocol.
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1.1.4. Specific Aim 2
The second aim was to determine whether a five day loading phase of an all-natural
antioxidant supplement during a summer cycling competition phase alters the basal level of
indicators of oxidative stress when compared to a placebo loading phase. The aim was examined
by determining the basal concentration of whole blood reduced glutathione, the ratio of whole
blood reduced glutathione/oxidized glutathione, and the concentration of plasma nitrotyrosine.
Hypothesis 2:
The antioxidant loading phase would result in an increase in the basal whole blood
concentrations of reduced glutathione, an increase in the basal whole blood reduced
glutathione/oxidized glutathione ratio, and a decrease in the basal concentration of
plasma nitrotyrosine as compared with a placebo protocol.
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1.1.5. Specific Aim 3
The third aim was to determine whether supplementation would alter the exercise-induced
acute oxidative stress in response to a high intensity cycling time trial after the performance of
90 minutes of cycling. The aim was addressed by examining the immediate post-exercise
concentration of whole blood reduced glutathione, the ratio of whole blood reduced
glutathione/oxidized glutathione ratio, and the concentration of plasma nitrotyrosine.

Hypothesis 3:
A multiple step antioxidant nutritional supplement protocol would result in the
attenuation of the decrease in whole blood reduced glutathione and the reduced
glutathione/oxidized glutathione ratio and the attenuation of the increase in plasma
nitrotyrosine that may occur in response to the cycle ergometry test as compared with a
placebo protocol.
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1.1.6. Specific Aim 4
The fourth aim was to determine whether supplementation would alter fuel metabolism in
trained male cyclists when compared to a multiple step isocaloric placebo. The aim was
examined by determining the concentration of plasma glucose, whole blood lactate production,
respiratory exchange ratio, and whole-body rates of fat and carbohydrate oxidation calculated
from the nonprotein respiratory exchange ratio during a validated repeated measure cycle
ergometry test.
Hypothesis 4:
A multiple step antioxidant nutritional supplement protocol would result in the
attenuation of the decrease in plasma glucose concentration and carbohydrate oxidation,
attenuation of the increase in whole blood lactate concentration, respiratory exchange
ratio, and fat oxidation during the cycle ergometry test as compared with a placebo
protocol.
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1.2. Background & Significance
Exercise results in an increased metabolic rate, which is associated with an increase in oxygen
consumption in the exercising tissues.63 Cycling is a mode of exercise that results in significant
increases in oxygen consumption as intensity increases49 and requires the athlete to maintain
high performance intensities for prolonged durations during competition.31 This fact is best
represented by the analysis of an individual time trial where competitive cyclists spend an
average of 20 minutes at >90% maximal oxygen consumption (VO2max).31 Additionally, it has
been reported that the winner of an individual time trial during the Tour de France cycled at
>90% VO2max for 70 minutes.77 The constant demand for energy is supplied to the working
muscle by the mitochondria, where oxygen is the final electron acceptor.63 The catabolic
processes in the mitochondria result in the formation of free radicals and other reactive oxygen
species,44 which subsequently leads to the formation of reactive nitrogen species.84 Metabolic
processes that occur during cycling intensities of ≥75% VO2max result in high rates of
carbohydrate oxidation, and supplementation with carbohydrate during an hour of cycling at
75% VO2max has resulted in a 2.3% increase in performance, determined by a decreased time
during a time trial.56 This increase in performance is considered an ergogenic benefit which is
stimulated by carbohydrate supplementation.
An ergogenic aid, such as energy substrates found in dietary supplements, generally result in
performance improvements during endurance exercise.5 The use of ergogenic aids has been
documented since ancient times.6 Current ergogenic aids include: energy sources, such as
carbohydrate; anabolic enhancers, such as protein and amino acids; and dietary antioxidant
cocktails.5, 81, 119 Antioxidants are substances that quench free radicals and reactive oxygen and
nitrogen species, thereby reducing the severity of oxidative stress.38 Oxidative stress occurs as a
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result of an imbalance between reactive oxygen and nitrogen species and the antioxidant defense
system.63 During high-intensity exercise, such as an individual time trial, the accumulation of
reactive oxygen and nitrogen species can occur.39
The accumulation of reactive oxygen and nitrogen species during a state of oxidative stress
can lead to oxidative injury during and after acute bouts of strenuous exercise,63 such as intense
aerobic exercise.5 Oxidative injuries can include lipid peroxidation18,18 and protein
oxidation,13,78,10 which may lead to oxidative muscle damage61 that can contribute to altered
cellular integrity and muscle metabolism and result in impaired muscular performance.70
Markers of muscle damage are routinely increased after prolonged high-intensity cycling.42,109,110
Furthermore, the red blood cell is also susceptible to oxidative damage.75, 79 Thus, when the
antioxidant defense system is inadequate and reactive oxygen and nitrogen species are not
controlled, accumulating levels of reactive oxygen and nitrogen species can result in oxidative
damage that could result in a chronic decrease in endurance performance due to muscle tissue
loss and decreased capacity to transport oxygen. The accumulation of oxidative damage is
relative to the production of reactive oxygen and nitrogen species63 and the collective success of
the antioxidant defense and muscle repair systems.65
The antioxidant defense system encompasses both nonezymatic and enzymatic antioxidants.
The nonenzymatic antioxidants include the exogenous antioxidant vitamins and endogenous
glutathione. The antioxidant vitamins are considered non-inducible antioxidants, meaning that
their concentrations are not altered with training adaptations.63 Inducible antioxidants respond to
training by adapting to quench higher levels of reactive oxygen and nitrogen species. Inducible
antioxidants include the enzymatic antioxidants and the glutathione antioxidant system.63
Enzymatic antioxidants superoxide dismutase and glutathione peroxidase have been shown to
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have increased activity levels after controlled endurance training.89 It is relevant to mention that
glutathione and Vitamins C and E are synergistic in their actions, meaning that these antioxidants
work together to neutralize reactive oxygen species.33, 53 This indicates that alterations in one of
these antioxidants can have an effect on the others (i.e. the use of α –tocopherol can compensate
for inadequacies in the glutathione antioxidant system). The only way to alter the antioxidant
vitamin concentrations is through modulation of dietary intake or dietary supplementation.63
Dietary antioxidants are susceptible to deficiency,63 and it is not uncommon for competitive
endurance athletes such as cyclists to have an inadequate dietary intake of antioxidants and
calories 78, 80 due to high caloric expenditure during training and competition. Furthermore,
many cyclists attempt to reduce body weight which may contribute to the effects stimulated by
an inadequate dietary intake. This maintenance of low body weight could create a scenario of
inadequate exogenous antioxidant intake. Based upon this line of reasoning it appears that
antioxidant supplementation could be beneficial for the maintenance of the exogenous
antioxidant system in these types of situations.
A few studies have investigated the effect of short term (≤14 days) antioxidant
supplementation on oxidative stress and performance.120,47,7 The supplementation protocols
varied in timing from 2 hours7 to 14 days47 prior to exercise. A graded cycling max test coupled
with ascorbic acid supplementation taken 2 hours prior to the high intensity aerobic exercise bout
was evaluated.7 Results indicated an increase in plasma ascorbic acid levels and a decrease in
oxidative stress at rest and in response to the exercise in healthy untrained subjects.7 This
indicates that short-term supplementation maybe beneficial in reducing oxidative stress by
attenuating uncontrolled production of reactive oxygen and nitrogen species that can lead to an
oxidative stress condition. Uncontrolled levels of reactive oxygen and nitrogen species during
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oxidative stress can result in oxidative damage which could lead to decreases in high intensity
aerobic exercise performance of longer duration or in subsequent performances during a
competitive season. An antioxidant energy substrate cocktail may provide increased levels of
protection beyond that of independently supplementing with only ascorbic acid, but there
currently exists no scientific literature evaluating this concept. Thus, more research on the
effects of short term antioxidant cocktail supplementation protocols on cycling performance in
trained athletes is warranted.
Exogenous antioxidant supplementation for 6 weeks has lead to improvements in cycling
performance during a laboratory time trial.81 However, it has recently been suggested that longterm antioxidant supplementation may be detrimental to cellular adaptations that lead to
improvements in endurance capacity.31 A number of cellular signaling pathways respond to
reactive oxygen and nitrogen species, which ultimately contributes to improvements in
endurance performance.65 So, the efficacy of long-term or chronic antioxidant supplementation
is currently being questioned in the scientific literature.65
It has also been speculated that long-term or chronic antioxidant supplementation could
prevent desirable adaptations in inducible antioxidants, limiting the adaptive capacity to deal
with reactive oxygen and nitrogen species.65 However, this may not occur in all situations. For
example, if an athlete has inadequate nutrient intake, the inclusion of an antioxidant
supplementation protocol may be warranted as it likely will attenuate oxidative stress-associated
muscle damage that can occur in athletes with low exogenous antioxidant intake during
simulated competitions,97 high intensity training, or during actual competitive events.
Regardless of exogenous antioxidant status, supplementation with dietary antioxidants
routinely results in decreased muscle damage in response to strenuous cycling in trained
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cyclists.42, 109, 110 This attenuation of muscle damage results in decreased muscular fatigue and
could preserve performance in times of intense competition, during periods of intensified
training such as overreaching, or at the onset of overtraining syndrome.33 Therefore, the timing
of antioxidant supplementation seems to be essential for allowing reactive oxygen and nitrogen
signaling to facilitate training adaptations, but high concentrations of reactive oxygen and
nitrogen generated during competition and during periods of overreaching must be controlled to
eliminate the possibility of the development of a chronic oxidative stress condition that would
result in detriments to performance.33
1.3. Limitations of Study
There were limitations within the implementation of this study. The ability to control for the
cyclists’ nutritional intake and training was limited. A dietary and training recall provided some
level of control, but this is only if the subjects took this practice seriously and accurately
recorded dietary intake and training rides. The consumption of foods and consistent training
without documentation into the supplied logs could have taken place and could be a confounding
variable. The lack of consumption of the desired dose of capsules during the loading phase
treatment period could further confound the results. The consumption of a single dose of the
antioxidant/energy substrate during step-two of the supplementation protocol may not be
adequate; it is possible that multiple daily doses prior to training could produce superior results.
Furthermore, a placebo effect could have resulted if subjects believed that they had the treatment
during the placebo trial. If the cyclist believed he was on the supplement, the level of motivation
may have been increased. This would have been due to expectations that the supplement
improves performance. Such motivational factors could indeed lead to false performance
improvements. The cyclists were also provided with data during the experimental trials and as a
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pacing strategy they may attempt to reproduce levels of the same power or heart rate values
during the experimental time trial, which could have resulted in similar performances. Some
basic assumptions include that the athletes gave a maximal effort throughout all testing
procedures and that they were unaware of the treatment given.
1.4. Operational Definitions
Antioxidant: Antioxidants are substances that quench free radicals and reactive oxygen and
nitrogen species thereby reducing the severity of oxidative stress.13, 27, 38
Dietary Antioxidant: A dietary antioxidant is a substance gained from food that may assist in
reducing the concentration of oxidative species and the muscle damage caused by free radicals
and reactive oxygen and nitrogen and has also been used as a therapeutic agent for muscle repair
processes during recovery.39
Endogenous Antioxidant: An endogenous antioxidant is a tissue antioxidant enzyme that is
important in the protection of cells against free-radical-mediated damage. The primary
antioxidant enzymes include superoxide dismutase, catalase, glutathione peroxidase, and
glutathione reductase. These enzymes are also referred to as the oxygen radical scavenger
enzymes.39
Exogenous Antioxidant: Exogenous antioxidants are dietary antioxidants that must be obtained
through the diet or dietary supplements.63
Ergogenic Aid: An ergogenic aid, such as a dietary supplement, results in performance
improvements.6
Free Radical: A free radical is a chemical species that contains at least one unpaired electron
and is produced in all living cells.15, 27

12

Glutathione Peroxidase: Glutathione peroxidase is the enzyme that uses reduced glutathione to
reduce hydrogen peroxide resulting in the formation of oxidized glutathione.87
Glutathione Reductase: Glutathione reductase is the enzyme that uses ß–nicotinamide adenine
dinucleotide phosphate to convert oxidized glutathione back into reduced glutathione.87
Isocaloric: Isocaloric means equating caloric content of two different supplement treatments
though the concentration of macronutrients is not the same (i.e. a carbohydrate+protein beverage
(200 kilocalories) and a carbohydrate-only beverage (200 kilocalories)).105
Lipid Peroxidation: Lipid peroxidation is the process of oxidizing fatty-acid side chains found in
membrane lipids to hydroperoxides; membrane lipids that contain two or more carbon-carbon
double bonds, a.k.a. polyunsaturated, have increased susceptibility to oxidation.45
Oxidation: Oxidation is the process of gaining oxygen or donating electrons (e.g. in the situation
of hydrogen peroxide formation where H2 reacts with O22-, the H2 is said to have undergone
oxidation because it donates electrons to O22- resulting in the formation of hydrogen peroxide).
In this reaction, H2 gains the oxygen.85
Oxidative stress: Oxidative stress occurs as a result of an imbalance between reactive oxygen
and nitrogen and the antioxidant defense system. Oxidative stress can result due insufficient
quenching of reactive oxygen and nitrogen by antioxidants, an overproduction of reactive
oxygen and nitrogen, or a drop in antioxidant defenses. Exercise is known to stimulate oxidative
stress.15, 27, 52, 53
Oxidized Glutathione (Glutathione Disulfide): Oxidized glutathione is produced during the
reactions of reduced glutathione with hydrogen peroxide.87 Oxidized glutathione is routinely
found to increase in response to exercise-induced oxidative stress.111
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Protein Oxidation: Protein oxidation is the process where cellular proteins are altered by reactive
oxygen and nitrogen species primarily at peptide bonds or amino acid side chains, leading to the
loss of catalytic or structural functions and leaving the protein highly susceptible to proteolytic
degradation.27
Reactive Nitrogen Species: Reactive nitrogen species include free radicals that are nitrogen bases
(e.g. nitric oxide (NO·), nitrogen dioxide (NO2·), and peroxynitrite (ONOO-)).15
Reactive Oxygen Species: Reactive oxygen species include free radicals that are oxygen based
(e.g. superoxide (O2·-), hydroxyl (OH·), alkoxyl (RO·), peroxyl (ROO·), and hydrogen peroxyl
(ROOH·)) and non-radicals such as hydrogen peroxide.15
Reduction: Reduction is the process of losing oxygen or accepting electrons (e.g. in the situation
of hydrogen peroxide formation where H2 reacts with the peroxide ion (O22-), the O22- is said to
have undergone reduction because it accepts electrons as it reacts with H2 resulting in the
formation of hydrogen peroxide). In this reaction molecular oxygen is lost in the formation of
molecular hydrogen peroxide.85
Reduced Glutathione: Reduced glutathione (γ-glutamylcysteinylglycine) is the most important
nonenzymatic antioxidant found in erythrocytes; reduced glutathione serves as substrate for
glutathione peroxidase and also directly quenches singlet oxygen and hydrogen peroxide.62, 87
Time Trial: A time trial in competitive cycling is either an individual or team event in which a
specific distance is covered as fast as possible.57 Laboratory time trials are endurance
performance tests with a known end point, such as a target amount of work or time, give the
subject control of resistance and pedal cadence, and are highly reproducible.58
Maximal oxygen uptake: Maximal oxygen uptake (VO2max) is a physiological characteristic that
is bound by the parametric limits of the Fick equation [(left ventricular end-diastolic volume) –
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(left ventricular end-systolic volume) x heart rate x arterio-venous oxygen difference] and is
continually found to be high in endurance athletes, most likely due to a high cardiac output, but
is not necessarily indicative of endurance athletic performance.75
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Chapter 2. Review of Literature
2.1. Introduction
Competitive endurance athletes routinely engage in strenuous exercise during competition31
that results in increases in oxygen consumption,81 increases in free radical associated damage,76
and disruption of the oxidant/antioxidant balance.64 This disruption favors the production of
oxidants, such as reactive oxygen and nitrogen species, which challenge the cellular antioxidant
defense system.33, 99 If the antioxidant defense system is inadequate or the exercise intensity or
duration is extreme, depletion of antioxidants can occur leaving reactive oxygen and nitrogen
species biologically active to react with cellular tissues and resulting in a situation known as
oxidative stress.15 Exercise increases metabolism and subsequently results in increased levels of
free radical and reactive oxygen and nitrogen species.32 Unrepressed reactive oxygen and
nitrogen species can result in cellular oxidative stress in which tissues are susceptible to
oxidative damage.63, 102
2.2. Free Radicals, Oxygen Radicals, and Nitrogen Radicals
During resting conditions the oxygen content in arterial and venous blood of skeletal muscle
tissue is 20 and 15 ml per 100 ml of blood, respectively; during exercise of an aerobic nature,
skeletal muscle arterial-venous oxygen differences increases by 3-fold, and skeletal muscle blood
flow increases by 30-fold.111 This large increase of blood flow during aerobic exercise is
necessary to support the increase in oxygen metabolism, as indicated by the arterial-venous
oxygen difference, due to increased energy consumption in the working skeletal tissue. Oxygen
radicals can be produced from the metabolism of oxygen during energy production.63 When a
biomolecule undergoes oxidation, it accepts an electron and is then considered to be oxidized. If
the electron is unpaired, the biomolecule is considered to be a free radical. According to Pauli’s
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principle, electrons should be accepted in anti-parallel fashion. Since the biomolecule dioxygen
already contains two unpaired electrons in a different anti-bonding orbital, the electrons being
accepted must have parallel spin to fit into the vacant orbital spaces. This imposes a restriction
on dioxygen and causes it to routinely accept only one electron at a time, resulting in formation
of the superoxide radical.46
The addition of a second electron to the superoxide radical results in the formation of a
peroxide ion, which is not a free radical because it contains no unpaired electrons.46 This
biomolecule is protonated immediately at physiological pH, resulting in the formation of
hydrogen peroxide.46 Like a peroxide ion, hydrogen peroxide cannot be considered a free radical
because it does not host an unpaired electron, but it can be considered a reactive oxygen species
because of its capacity to generate reactive oxygen species.33 For example, one product from
Fenton’s reaction between hydrogen peroxide and ferrous ion is a hydroxyl radical, which reacts
with tissues causing the oxidation of membrane lipids, termed lipid peroxidation, and protein
oxidation.74
Reactive oxygen species are not the only biomolecules that interact with tissues causing lipid
peroxidation and protein oxidation. Nitrogen radicals form when reactive oxygen species
interact with nitric oxide to produce reactive nitrogen species.123 Reactive nitrogen species
include nitrogen dioxide, and peroxynitrite. Reactive nitrogen species also react with
biomolecules, causing lipid peroxidation126 and premature protein degradation due to
nitrosylation.115 Thus, when reactive oxygen species accumulate there is a greater chance in the
formation of reactive nitrogen species.
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2.3. Production of Reactive Oxygen and Nitrogen Species during Exercise
Healthy resting muscle produces low amounts of reactive oxygen species,91 which is easily
handled by the antioxidant system.33 However, in conditions of disease and chronic stress, such
as exercise, the antioxidant system can become overwhelmed by the accumulation of reactive
oxygen species, leading to cellular damage.33 This damage may occur as a result of the oxidation
of membrane lipids45 and proteins,115 which increases in exercising muscle due to the increases
in free radicals.18 If the damage is excessive, a loss of muscle function may occur.91
Mitochondria are known to be a significant source of reactive oxygen species in working muscle
tissue during exercise.21 Other sources of reactive oxygen species due to oxidation include
myoglobin and hemoglobin.125 In addition to reactive oxygen species, reactive nitrogen species
are also produced during exercise.40
2.3.1. Reactive Oxygen Species Production
It is postulated that the increase in oxygen demand of the skeletal muscle during acute bouts
of aerobic exercise results in increased concentration of superoxide.39 Intense physical exercise
results in increased free radical production from the muscle mitochondria,74 which is mostly due
to increased oxygen flux through the electron transport chain.63 Reactive oxygen species
formation has been found to be proportional to electron transport chain activity.21 Generally
oxygen is the final acceptor of two electrons at the end of the electron transport chain and 9599% of the time is reduced to water.32 However, it actually prefers to receive one electron at a
time, due to Pauli’s principle requiring the incoming electrons to have parallel spin.46 Thus, the
remaining 1-5% oxygen receives only one electron,54 leading to the generation of a superoxide
radical55 at complex I and III90 which may result in damage to the mitochondria.35, 74 This
mitochondrial damage can then cause alterations in the function of the electron transport chain35
and increased oxygen loss.53 Mitochondrial damage can lead to further reactive oxygen species
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production and additional mitochondrial damage, which can contribute to an energetic decline35
as a result of the mitochondria no longer being able efficiently produce ATP due to oxygen loss.
It is proposed that during exhaustive exercise, mitochondrial disruption can lead to a further loss
of cell function, cell necrosis, muscle damage, and inflammation.30, 59, 19
The oxidation of hemoglobin can also be a source of reactive oxygen species; about 3% of
total hemoglobin undergoes auto-oxidation, resulting in the formation of superoxide.52 The
oxidation of the red blood cell is of particular interest due to their concentration of
polyunsaturated fatty acids and heme iron, which makes erythrocytes particularly susceptible to
oxidative damage.113 Myoglobin is susceptible to both free radical oxidation and autooxidation.125 Auto-oxidation occurs when ferrous iron, present in myoglobin and hemoglobin,
reacts with oxygen to form superoxide.125
2.3.2. Reactive Nitrogen Species Production During Exercise/ Interaction with Reactive
Oxygen Species
Acute exercise has been found to result in increases in reactive nitrogen species formation,
specifically nitric oxide, and to alter nitric oxide synthase activity.104, 68 During physical
exercise, increases in blood flow and shear stress in the vascular system triggers the release of
nitric oxide in order to enhance vascular function.92 It has also been proposed that nitric oxide
may be influenced by repetitive muscle contractions during exercise.103 In addition to the
influence of reactive oxygen species, nitric oxide may also influence the oxidant-antioxidant
balance in skeletal muscle.103 It has been speculated that increases in reactive oxygen and
nitrogen during aerobic exercise contributes to increased oxidative cellular damage.102
2.4. Determining Reactive Oxygen and Nitrogen production during exercise
The direct quantification of free radical production in response to oxidative stress is difficult
to perform due to the extremely short half life of the free radical biomolecule.15 The most
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sensitive direct measure of free radical concentration is electron spin resonance spectroscopy,
which is performed in conjunction with spin trapping techniques.121 This technique has been
used to examine free radical concentrations in the blood of exercising humans. The results of
these blood analyses demonstrate an increase in the free radical adduct, α-phenyl-tertbutylnitrone, and consequent free radical damage as assessed by lipid peroxidation.8 However,
most studies investigating the effects of cycling exercise on oxidative stress have generally used
secondary measures such as free radical induced lipid and protein oxidation to estimate free
radical production.10, 89
Expired pentane, a possible by-product of lipid peroxidation, was one of the first
measurements made to associate reactive oxygen and nitrogen damage and cycling exercise.22
The accumulation of reactive oxygen and nitrogen results in lipid peroxidation and may also
contribute to cellular protein oxidation.17 An increase in protein oxidation has been observed in
response to a single day of a cycling stage race that was considered to be of moderate intensity,14
indicating the presence of oxidative stress in response to a single day of cycling competition.
The damage sustained by the muscle cell through this lipid and protein oxidation could
contribute to altered cellular integrity and metabolism, resulting in impaired muscular
performance.106
The oxidation of muscle cells is one of the processes that leads to altered protein function, but
tyrosine nitration during inflammatory conditions is also linked to altered protein function.27 It is
suggested that reactions between nitric oxide and reactive oxygen species result in the formation
of nitrogen oxide intermediates, such as peroxynitrite, which nitrate proteins.123 Tyrosine
residues found on proteins are susceptible to nitration by peroxynitrite, resulting in alteration of
the physiological functions of these proteins and ultimately degradation.115 More specifically,
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peroxynitrite reacts directly with thiols, such as glutathione at its disulfide bonds, and
hemoproteins at their metal centers and lipid membranes.99, 88 The product of tyrosine nitration,
nitrotyrosine, can therefore also be used as a marker of oxidative stress3, 123 and provide an
indication of the potential for oxidation of thiols and hemoproteins.
Levels of serum nitrotyrosine have been shown to rise significantly during a four-day supermarathon.100 This rise in protein nitration indicates the occurrence of oxidative stress to proteins
in well-trained endurance athletes. The event was extreme in nature, in that it lasted for four
consecutive days totaling 328 km, and one might argue that an event this extreme may not relate
to usual competitions in which most endurance athletes engage. With that in mind, it is
necessary to point out that the levels of serum nitrotyrosine increased after the first day from 9
mmol·L-1 to 17 mmol·L-1, which consisted of 93 km of running, where they remained for the
duration of the competition.100 So, it is plausible that endurance exercise lasting only one day
will still increase oxidative stress as indicated by increases in nitrotyrosine100 and markers of
protein oxidation.14 Ultimately, the accumulation of the oxidative damage is relative to the
collective success of the antioxidant and muscle repair systems,101 training status,82, 96 and
intensity of the exercise.49
2.5. Antioxidants Fluctuations, Cell Damage, and Oxidative Stress
The antioxidant defense system is the body’s endogenous defense mechanism that can
neutralize reactive oxygen and nitrogen species64 and attenuate reactive oxygen and nitrogen
species induced oxidative damage. Oxidative stress results when the antioxidant system is
overloaded and can no longer neutralize the concentration of reactive oxygen and nitrogen
species being produced.64, 13 In a state of oxidative stress, reactive species are not controlled and
spontaneous reactions of reactive oxygen and nitrogen species with other oxygen, nitrogen, and
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sulfur species occurs and causes a cascade of free radical formation,33 which exhausts the
antioxidant defense system and leads to muscle cell96 and red blood cell damage.113, 116, 117 Thus,
when the antioxidant defense system is inadequate, damage can occur that might result in
decreased endurance performance due to muscle tissue loss and decreased capacity to transport
oxygen. Although not directly indicative of tissue damage, a popular technique for determining
oxidative stress includes measurement of antioxidant concentration fluctuations because changes
in the concentration of antioxidants can point to impairment in the antioxidant defense system.94
The antioxidant defense system consists of enzymatic (endogenous in origin) and non-enzymatic
(exogenous in origin) antioxidants,98 and it is usually the exogenous antioxidants that are
susceptible to deficiency.63
2.5.1. Non-Enzymatic Antioxidants: Ascorbic Acid and α –Tocopherol
Some of the non-enzymatic, exogenous antioxidants include ascorbic acid and α –
tocopherol.33 Ascorbic acid is known to scavenge free radicals in the aqueous phases of cells
and in the circulatory system, as well as to protect cell membranes from oxidative damage.9 It
has been demonstrated that supplementation with ascorbic acid attenuates the release of creatine
kinase after muscle-damaging eccentric exercise.13 It is plausible that ascorbic acid decreases
oxidative stress by scavenging reactive oxygen species or by regenerating the antioxidant form
of α –tocopherol 9 to result in the decreased muscle damage.
Endurance-trained cyclists who were supplemented with ascorbic acid for a period of two
weeks, and after 2.5 hours of cycling at 60% VO2max demonstrated no reduction in oxidative
stress, as indicated by markers of lipid peroxidation. This suggests that ascorbic acid
supplementation alone is ineffective at reducing oxidative stress.19 However, interpretation of
this data must be taken with caution. Cycling at 60% VO2max may not be of adequate intensity to
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invoke oxidative stress and is therefore not ideal for determining beneficial effects of antioxidant
supplementation on oxidative stress that might be seen in response to competition or high
intensity training. This contention may be supported by the fact that the authors were unable to
report significant differences in levels of oxidative stress in response to the cycling bout during
the treatment or placebo intervention.19 Without invoking oxidative stress during the exercise, it
is difficult to determine the effect of supplementing with ascorbic acid on oxidative stress during
cycling.
A similar study design was employed to investigate the effects of coupled ascorbic acid and α
–tocopherol supplementation on oxidative stress in response to cycling.20 This protocol
consisted of consumption of the antioxidants or placebo for four weeks and investigated the
oxidative stress response to 2.5 hours of cycling at 60% VO2max in recreationally active males.
The determining measures of oxidative stress were indicators of lipid peroxidation, F2isoprostanes and thiobarbituric acid reactive substances. Results indicate an increase in F2isoprostanes after exercise but no difference in the increases between treatment groups. The
thiobarbituric acid reactive substances did show an alteration due to the supplementation, which
resulted in a significant decrease in thiobarbituric acid reactive substances after the exercise
versus the placebo group. The authors conclude that although a decrease in thiobarbituric acid
reactive substances was observed as a result of supplementation, there was no conclusive
evidence between the two measures to suggest that oxidative stress was attenuated as a result of
the supplementation protocol.20
It is likely that the cycling protocol was not of a high enough intensity to induce oxidative
stress. The intensity used is not comparable to the intensities observed during actual competitive
cycling. Cycling intensities encountered during competitions are ≥75% VO2max,31 a higher
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intensity than what was used in this study. Therefore it is difficult to conclude that the
combination of ascorbic acid and α –tocopherol supplementation would not make a difference in
reducing oxidative stress during a cycling competition.
However, data exists that suggests α –tocopherol is an important antioxidant in maintaining
endurance performance. It has been demonstrated that rested α –tocopherol deficient animals
exhibit similar concentrations of free radicals and lipid peroxidation as exercise-exhausted
animals.18 During exercise, the α –tocopherol deficient animals exhibited a 40% lower
endurance capacity than non-deficient controls.18 Thus, an increase in lipid peroxidation, as seen
during oxidative stress conditions, may contribute to decreased endurance capacity.
Supplementation with ascorbic acid has also been demonstrated to prevent increases in
oxidative stress during exercise. The attenuation of the increase in the ratio of blood oxidized
glutathione to total glutathione, an indicator of oxidative stress, was reported during muscledamaging exercise as indicated by increases in concentrations of creatine kinase.13 Endurance
exercise at the intensities encountered during competitive cycling are known to significantly
increase creatine kinase.42 Thus, it appears that antioxidant Vitamins C and E are important in
endurance capacity by decreasing oxidative stress, leading to attenuation of oxidative tissue
damage.
2.5.2. Non-Enzymatic Antioxidant: Glutathione
The non-enzymatic antioxidant reduced glutathione is relevant to oxidative stress.87 Reduced
glutathione is able to protect cells from the toxic effects of reactive oxygen species by
detoxification of reactive oxygen species and reactive oxygen species products (i.e. peroxides)87
and is used by glutathione peroxidase to neutralize hydrogen peroxide, resulting in the formation
of oxidized glutathione. 87 Reduced glutathione is considered the most important non-enzymatic
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antioxidant found in erythrocytes. Blood reduced glutathione concentrations are generally
between 800-2000 µM,28, 29, 66 and oxidized glutathione concentrations vary depending on free
radical induced oxidative stress but have been found to be between 2.0-800 µM.28, 29, 66
Concentrations also vary depending on the subject’s level of training,71 nutritional intake,51, 66 as
well as in response to different types of exercise intensities34, 49 and durations of exercise.24, 26, 37
Training increases the basal reduced glutathione concentration in the blood28 thereby providing
increased protection against oxidative species during exercise. It has been reported that
fluctuations in the glutathione antioxidant system are sensitive to exercise intensities, with
greater intensities resulting in greater decreases in reduced glutathione.34
Under conditions of oxidative stress, a consistent determining marker is blood glutathione
oxidation.112 A decrease in the reduced glutathione/oxidized glutathione ratio and total
gluthation concentration is routinely shown in the blood of exercising humans,28, 29, 37, 71, 118 while
oxidized glutathione/total glutathione increases.13, 108 This indicates an increase in oxidized
glutathione, while the reduced glutathione is decreased, which occurs as glutathione reacts with
reactive oxygen and nitrogen and attenuates further increases in reactive oxygen and nitrogen
species that could result in oxidative stress.
2.5.3. Glutathione and Cycling
Research indicates that cycling at 65% VO2max for 90 minutes over three consecutive days in
moderately trained subjects can decrease the reduced glutathione/oxidized glutathione ratio
during the bout of cycling.124 This reduction in reduced glutathione/oxidized glutathione ratio
appears to rebound back to pre-exercise levels within 15 minutes after cessation of exercise.
This rapid rebound is due to the recycling nature of the glutathione antioxidant system. Oxidized
glutathione reacts with NADPH to reform reduced glutathione. Measuring the reduced
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glutathione/oxidized glutathione ratio level chronically over the consecutive days did not result
in any significant deviations from baseline. Thus, there appears to be no cumulative effective on
the reduced glutathione/oxidized glutathione ratio level, making it ideal to examine acute
exercise induced oxidative stress in trained cyclists.124 Cycling at 65% VO2max can result in
oxidative stress but does not result in increased oxidative damage, as assessed by RNA damage.
The authors conclude that although oxidative stress occurs during submaximal prolonged
endurance cycling, the stress encountered does not have any cumulative effects.124
In another study, cycling at 65% VO2max for 90 minutes in moderately trained subjects
resulted in a 60% decrease in reduced glutathione and a 100% increase in oxidized glutathione
concentrations when compared to non-exercise levels.37 Although these exercise models did
induce oxidative stress, they do not model intensities that competitive endurance cyclists usually
encounter during high intensity training or competition, making it difficult to determine if
oxidative damage results from oxidative stress during high intensity cycling.
Intensities of greater than 75% VO2max are reported for 93 minutes on typical flat stages and
123 minutes during hilly stages of a competitive professional stage race.31 These intensities and
time frames are reported from cycling competitions that engage the world’s best cyclists, so it is
unlikely that researchers will have access to athletes that are able to reproduce these exact
intensities for a similar period of time. It seems appropriate to reproduce these intensities
because oxidative stress is increased with increases in exercise intensities as determined by the
glutathione antioxidant system.34 Thus, it is important to define at intensities of 75% VO2max or
greater.
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2.5.4. Glutathione’s Synergistic Effect
Glutathione is considered to be a key antioxidant due to its ability to detoxify reactive oxygen
species directly and enhance the function of other exogenous antioxidants, such as ascorbic acid
and α-tocopherol.43, 84 Enhancing the reduced glutathione concentration in cells may increase
their resistance to oxidative damage.87 Mitochondrial oxidative damage has been associated with
muscle degeneration in reduced glutathione depleted animals;83 as such, a cellular deficiency of
reduced glutathione can be associated with oxidative damage. The administration of ascorbic
acid and α-tocopherol in a reduced glutathione deficient state results in attenuation of cellular
damage,114 which demonstrates the cooperative effectiveness of the exogenous antioxidants and
the importance of reduced glutathione in preventing oxidative damage. Therefore, one could
reason that the administration of not one but many exogenous antioxidants would result in
greater attenuation of oxidative stress-induced damage, possibly through maintenance of the
glutathione antioxidant system during acute exercise. During induced overtraining in trained
triathletes the basal concentration of reduced glutathione was actually increased in response to
antioxidant supplementation with ascorbic acid, α-tocopherol, and selenium.96 Furthermore,
reduced glutathione is a very important molecule to the cell in that it prevents oxidative damage
but also in regulation of redox-sensitive tissue signal transduction.111
2.6. Reactive Oxygen and Nitrogen Species and Signal Transduction
Although most of the research on reactive oxygen and nitrogen species has focused on the
deleterious effects associated with disease and tissue damage,102 reactive oxygen and nitrogen
species have also been shown to regulate an increasing number of signal transduction
pathways.91 During exercise the increase in reactive oxygen and nitrogen species could induce
adaptive mechanisms involving antioxidant and repair systems.102 Regulatory elements such as
kinases, phosphatases, and transcription factors appear to be redox-sensitive. Fluctuating
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concentrations of reactive oxygen and nitrogen species exert effects on cell signaling pathways
through these regulatory mechanisms, which can alter gene expression and muscle adaptation.91
Oxidative stress-sensitive signal transduction pathways include the nuclear factor (NF) κ B
and mitogen-activated protein kinases (MAPKs). MAPKs are involved in cell functions that
include cellular growth, proliferation, and adaptation. NF-κ B activation by reactive oxygen and
nitrogen species signals for enhanced gene expression of important antioxidant enzymes (e.g.
mitochondrial superoxide dismutase) due to NF-κ B binding sites in these gene promoter regions.
Furthermore, acute treadmill running (58 ± 7 minutes) in animals results in significant increases
in the protein levels of extracellular signal-regulated kinases (ERK) 1/ERK2 and p38 MAPK in
the upstream NF-κ B signaling pathway, providing further support that reactive oxygen and
nitrogen species are involved in activating MAPK. This is evident when the administration of
allopurinol abolishes production of reactive oxygen and nitrogen species, ultimately attenuating
the phosphorylation of these enzymes and resulting in decreased ERK1/ERK2 and p38 MAPK
protein levels.65 This demonstrates that reactive oxygen and nitrogen species are important in
cellular adaptations that signal for enhanced antioxidant defenses and muscle adaptation.
Furthermore, NF-κ B activation is also sensitive to intracellular thiol redox status. Low levels
of cytosolic oxidized glutathione are associated with diminished activation of NF-κ B. On the
contrary, high oxidized glutathione or low reduced glutathione concentrations inhibit the binding
site of activated NF-κ B to antioxidant gene promoter regions. Subsequently, either condition is
limiting appropriate signals that would result in upregulation of antioxidant defenses. This
highlights the concept that there seems to be an intermediate, ideal, intracellular concentration of
oxidized glutathione needed to facilitate effective NF-κ B activation.23, 111 This is important
when considering the use of antioxidants during exercise and their effects on the glutathione
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antioxidant system. It could be reasoned that cellular adaptations will be blunted if treatment
with antioxidants results in extremely low levels of oxidized glutathione. But, if too high of a
concentration of reactive oxygen and nitrogen species results from a cascade of free radicals
during exercise-induced oxidative stress, copious amounts of reduced glutathione will be
oxidized to oxidized glutathione, resulting in inhibition of the appropriate cellular signals that are
necessary to increase the antioxidant defense system. Therefore, it is ideal to examine the
glutathione antioxidant system when investigating the effects of antioxidant supplementation.
Although it appears an ideal physiological level is necessary for desirable signaling events the
specific concentrations have not been reported. Cellular research leading to this hypothesis of an
ideal concentration is based on the administration of buthionine sulfoximine to deplete reduced
glutathione and pyrrolidinedithiocarbamate to replenish reduced glutathione.111 The actual
concentration of reduced glutathione or oxidized glutathione was not measured.
2.7. Efficacy of antioxidant supplementation
The efficacy of antioxidant supplementation is currently in question due to the concept that
attenuation of reactive oxygen and nitrogen species by antioxidant quenching mechanisms will
result in diminished cellular adaptations that are seen to be beneficial to oxidant-antioxidant
homeostasis.65 However, long-term supplementation of six weeks has resulted in improvement
in cycling time trial performance.81 It is conceptualized that antioxidant supplementation will
reduce oxidative stress and oxidative stress-associated muscle damage, though research in this
area provides varying results.69 An underlying reason for discrepancies in the literature could be
a result of the exogenous antioxidant intake by the subjects independent of the
supplementation.39 There exists a delicate balance between reactive oxygen and nitrogen species
eliciting adaptation and reactive oxygen and nitrogen species resulting in accumulation of
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oxidants. For individuals who engage in high-intensity aerobic exercise, antioxidant
supplementation may provide a larger protective margin against the detrimental effects of
reactive oxygen and nitrogen species.63
Cyclists routinely engage in high-intensity aerobic exercise during training and
competitions.31 Additionally, competitive cyclists must maintain a low body weight by
decreasing caloric intake to achieve maximal relative power measures. This is imperative when
evaluating uphill cycling performance where a gain of 3 kilograms of body weight could
decrease performance by 1:15 (minutes:seconds) during a 20 kilometer time trial on a 6 %
grade.61 Complicating the matter further is the fact the cyclists burn a huge number of
kilocalories, approximately 500 per hour depending on intensity, and without supplementation
can have inadequate nutritional intake of antioxidants during days of intense competition.107
Even though some adaptation of the antioxidant systems can occur,102 the adaptations may not be
adequate to prevent oxidative damage in a nutrient-deficient state.97 Thus a nutritional
supplement that provides antioxidants and energy does seem to be ideal for some endurance
athletes.80,63
2.8. Antioxidant and Energy Substrate Supplementation
Using a two day protocol [75% VO2peak for Day 1, 85% VO2peak Day 2] in 15 male cyclists
(VO2max 52.6 ± 10.3 ml·kg-1·min-1), researchers demonstrated that time to fatigue can be
increased by 29% for the first ride and by 40% for the subsequent ride with the consumption of a
carbohydrate + protein drink compared to carbohydrate only. This finding could possibly be due
to the higher caloric content of the carbohydrate + protein beverage used in the study. The
carbohydrate + protein beverage contained 25% more calories than the carbohydrate beverage,
4:1 carbohydrate:protein, 7.3% carbohydrate and 1.8% protein. The beverage was consumed
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every 15 minutes during the cycling bout (1.8 ml·kg-1) and immediately after (10 ml·kg-1).109
Although the performance data from this study could be due to higher energy content, another
relevant finding was a decrease in creatine kinase levels. The concentration of creatine kinase
was 83% lower when comparing the post-exercise values between carbohydrate + protein and
carbohydrate (216.3 ± 122.0 versus 1318.1 ± 1935.6 U·L-1).109 Thus, consumption of a beverage
with carbohydrate + protein during and after cycling seems to attenuate muscle damage resulting
in improved performance.
Using a similar study design, the same group examined the effect of a carbohydrate + protein
gel versus carbohydrate gel on performance in 8 male and 5 female cyclists (VO2Peak=57.9 ml·kg1

·min-1). In this study the cyclists rode 13% longer with the carbohydrate + protein gel (116.6 ±

28.5 minutes) versus the carbohydrate gel (102.8 ± 25.0 minutes). The supplement design
maintained a 4:1 carbohydrate:protein ratio. Again, the supplements were matched for
carbohydrate concentration and the carbohydrate + protein had a higher caloric content, which
may have accounted for part of the performance difference seen between treatments. The gels
both contained 0.15 g·kg-1 of carbohydrate, and the carbohydrate + protein gel also contained
0.038 g·kg-1 of protein. The creatine kinase levels were increased after exercise for both
treatments, but the increase was only significant for the carbohydrate treatment.110 Thus, the
carbohydrate + protein gel may have attenuated muscle damage, which lead to improvements in
performance.
These studies demonstrate that the use of a supplement containing both carbohydrate and
protein can decrease markers of muscle damage. The addition of extra calories in the form of
protein seems to prolong exercise to exhaustion, and this performance improvement is enhanced
over subsequent days. A longitudinal study comparing the effects of isocaloric carbohydrate and
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carbohydrate + protein supplements in two groups of cyclists matched for performance could
provide the answer as to whether there are any benefits of using a carbohydrate + protein
beverage or gel to decrease creatine kinase levels. One could reason that a reduction in muscle
damage between bouts of fatiguing exercise could decrease recovery time leading to a higher
training volume and intensity. This increase in training quality could ultimately lead to
measurable improvements in performance.
Recent research109 reports a decrease in muscle damage from the use of a carbohydrate +
protein beverage versus carbohydrate only, suggesting that this decrease in muscle damage
should lead to performance maintenance in subsequent rides. This lead to the examination of the
effects of two different isocaloric drink supplements, carbohydrate-protein-antioxidants versus
carbohydrate, on cycle ergometry to fatigue in 14 moderately fit male cyclists (VO2Max = 59.8 ±
11.9 ml·kg-1·min-1).105 Cyclists underwent two rides to fatigue, one at 70% VO2peak on day 1 and
another at 80% VO2peak on day 2 (22-24 hours later) to examine the effects of the supplements on
performance during subsequent fatiguing rides. This protocol was also chosen to mimic day-today training and dietary practices that are common in competitive cyclists. Blood samples were
drawn for determination of plasma lactate dehydrogenase at baseline and 72 h after the first bout
of fatiguing exercise and for plasma creatine kinase at baseline and 24 hours after the first
exercise bout. These sampling points were chosen because the examined measures should
exhibit peak concentrations at these time points.105 The supplements consisted of a 12 ounce
beverage to be consumed during the exercise [carbohydrate-protein-antioxidants: 139 kcal, 7.5%
carbohydrate, 1.8% protein, 200% RDA for Vitamins C and E; carbohydrate: 140 kcal, 12 oz,
9.3% carbohydrate] and another 12 ounce beverage of higher nutrient density to be consumed
immediately after the exercise [carbohydrate-protein-antioxidants: 277 kcal, 15% carbohydrate,
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3.6% protein, 1330% RDA for α –tocopherol , 780% RDA for ascorbic acid; carbohydrate: 277
kcal, 18.6% carbohydrate]. There was no difference in performance between the carbohydrate
and carbohydrate-protein-antioxidants according to the total performance time (138.1 ± 39.3
versus 140.9 ± 43.7 minutes). However, the concentration of creatine kinase revealed a
significant attenuation of muscle damage when comparing baseline versus 24 hours with the
carbohydrate-protein-antioxidants supplement (187.5 ± 119.0 versus 272.9 ± 169.4 U·L-1) when
compared to the carbohydrate supplement (202.6 ± 120.0 versus 582.0 ± 474.9 U·L-1). Lactate
dehydrogenase was significantly elevated at 72 hours after the first bout of exercise in the
carbohydrate versus carbohydrate-protein-antioxidants (495.1 ± 63.7 U·L-1 versus 450.7 ± 43.1
U·L-1).105
Increased creatine kinase and oxidative stress have been associated with triathletes during
induced overreaching. These athletes presented with higher creatine kinase values at rest and in
response to a duathlon test after four weeks of overreaching.96 Oxidative stress was shown to
increase in response to the overreaching as indicated by decreases in the reduced
glutathione/oxidized glutathione ratio, which was reduced further in response to a cycling and
running duathlon test.96 Thus, it appears that increased levels of muscle damage occur in
conjunction with oxidative stress. This study also demonstrates that in times of increased
training stress, specifically induced overreaching, the antioxidant system may not adequately
adapt, leaving the body susceptible to oxidative damage.
In a similar study of induced overreaching in triathletes, antioxidant supplementation with
selenium (150 μg·day-1), retinyl acetate (1 mg·day-1), ascorbic acid (120 mg·day-1), α-tocopherol
(1 mg·day-1) enhanced the glutathione antioxidant systems adaptations. The level of reduced
glutathione increased significantly during overreaching in the supplemented group. Furthermore,
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creatine kinase was attenuated in the supplemented group in response to the duathlon test. It is
important to note that these athletes did present with inadequate antioxidant nutritional intake
prior to supplemenatation.97 So, it appears that in athletes with deficient exogenous antioxidant
intake, supplementation can enhance the adaptations of the endogenous glutathione antioxidant
system during periods of induced overreaching and result in attenuation of muscle damage in
response to a mock competitive event. The increases in reduced glutathione levels provide an
extra level of protection against exercise-induced oxidative injury.
There is evidence that consumption of antioxidant energy substrate cocktail increases
endurance performance. The cycling protocol engaged trained cyclists in a maximal effort 30
km time trail. After supplementation for 6 weeks the test group demonstrated a 3% increase in
performance.81 This could have been due to a reduction in muscle damage, alterations in the
endogenous antioxidant systems, or an increase in exogenous antioxidant consumption.
For an overview of relevant supplement studies according to ingredients in the planned
treatment intervention refer to Table 1 in appendix D.
2.9. Cycling Performance
Cycling is a dynamic sport, and currently no one laboratory measure predicts the best
competition performer out of a group. Many direct and indirect methods exist to determine
aerobic endurance performance capacity.11 One measure of aerobic capacity uses a graded
exercise test to determine VO2max. This measure provides a good indication of the capacity of
the cardiovascular system and is sometimes referred to as maximal aerobic power.75 Maximal
aerobic power is of some importance to cyclists, but many other variables also contribute to
cycling performance in addition to VO2max, such as skeletal muscle adaptations and alterations in
fuel metabolism.48
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The discussion of performance in cycling should consider aerobic endurance capacity and the
ability to cycle at a high percentage of VO2max for a prolonged duration.11 But many factors
contribute to a cyclist’s success; power-to-weight ratio and power production at lactate threshold
(LT)16 are also important factors. Furthermore, the cyclist’s economy is relative to the power
that can be sustained at a given percentage of the VO2max,67 which is related to the cyclist’s LT.
Another indicator of performance is the ventilatory threshold (VT) determined by breakpoint
of ventilatory equivalent of oxygen or carbon dioxide (VE/VO2 or VE/VCO2) and respiratory
exchange ratio (RER).4 The VT has been identified as being accurate in predicting cycling 40
kilometer time trial performance.4 Furthermore, LT is correlated with performance but is not
representative of race pace for cycling time trials.70 During a simulated 20 kilometer time trial,
cyclists were able to ride at intensities greater than their predicted LT of 2 mmol·L-1 above
baseline, as determined during a graded max test, for over 30 minutes.70 It must also be
emphasized that motivational and psychological factors can contribute to a cyclist’s athletic
performance, and there is currently no test to determine the contribution of these factors to
performance. Therefore, there is no scientific method that totally examines the performance of a
competitive cyclist in the lab.67
During competition, cycling requires the athlete to maintain high intensities for prolonged
durations.31 This fact is best represented by the analysis of an individual time trial where
competitive cyclists spend an average of 20 minutes at >90% VO2Max.31 Additionally, it has been
reported that the winner of an individual time trial during the Tour de France cycled at >90%
VO2Max for 70 minutes.77 Thus, intensities taken from actual cycling competitions can be
reproduced in the testing laboratory to simulate realistic racing conditions. In previous studies,
cycling during a 30 minute time trial in the laboratory setting resulted in a heart rate that was
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consistently 90% of max.25 Furthermore, it had been reported that heart rate at the onset of blood
lactate (OBLA) and power output at a fixed blood lactate level of 4 mmol·L-1 is similar to the
heart rate achieved during performance of approximately 10-39 minutes in elite cyclists.95
The analysis of cross-country mountain bike competitions reveals similar intensities as during
competitive road cycling time trials.50 The cross-country cyclists spent 31% of the mountain
bike competitions above OBLA. The average heart rate during 5 competitive cross-country races
averaged out to be 90% of HRmax for 147 minutes.50 Thus, cycling at high intensities is welldocumented during both mountain bike competitions and road cycling time trials.
The classification of the athletes’ performance level may also be a contributing factor to the
difficulty in drawing comparisons between studies.60 A non-systematic approach of quantifying
performances has lead to some confusion among outcome measures during cycling studies.
Thus, performance classifications such as “elite” have variable meanings between colleagues,
making comparisons among studies unreliable. In 2000, a unified classification system was
proposed by Jeukendrup et al.60 that allows for the universal comparison of cycling research.
Using this systematic approach for classification of the cyclists’ level of performance will allow
data to be compared across multiple publications. Thus, the systematic approach including both
performance measures and quantification of training and racing history60 allows for better
classification of a cyclist’s actual performance level.
2.10. Appropriate protocol for examining nutritional intervention
The use of test/re-test protocols during cross-over study designs to measure the effect of
supplementation and training implementation on performance is widely accepted. 105, 109, 110
However, just because a test offers some measure of performance (i.e. VO2max or LT) does not
mean that improvements in test performance will translate to competitive performances, or that
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the athlete has improved at all. It could simply be that the athlete has improved performance
during the test due to increased motivation or due to familiarization with the test protocol during
previous testing procedures. Tests must be reliable and validated, and the athlete must be
familiarized with the test prior to performance data is collected.
One of the most reliable methods of determining improvements in cycling performance is to
first provide the athlete with a preliminary familiarization ride where the subject is preloaded
with a set time and work rate (i.e. 45 minutes at 70% maximal power output). The cyclist
subsequently undergoes a work time trial at simulated race pace, performing as much work as
possible within a pre-set amount of time (i.e. 15 minutes) normally at intensities of ~90%
HRmax, which is similar to those encountered during competitive cycling competitions.29, 74, 25,
95, 50

During the treatment period, the actual testing protocol includes the preload, followed by a

timed bout reaching the previously determined amount of work that was completed in the final
15 minutes during the familiarization ride.58 This preload+time trial technique is a reliable
test/retest protocol, as indicated by a coefficient of variance of 3.49%.58
Another consideration is the familiarity of the cyclists to the testing protocol. Usually the
more familiar the cyclist becomes with the test, the better his performance will be.58, 73 A control
used to minimize this problem is the familiarization ride. The cyclist will complete the testing
protocol without any treatment intervention (i.e. a preliminary ride). This ride will act as the
learning curve so that under the treatment conditions that athlete will have already experienced
the test. The cyclist will then repeat the protocol under the treatment or placebo conditions for
an actual measure of performance.73
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2.11. Limitations in Current Supplement Research
Some limitations of the above research reviewed include variability in the duration of fasting
prior to the bout of exercise, the control of outside diet and exercise, and time between
administrations of the treatment or placebo in the crossover designs (washout periods).
Generally the literature reports recovery/washout periods varying in length of time, from 6-14
days110, 109, 105 between treatment trials. This variable length of time can make it difficult when
analyzing data from different studies. When comparing dietary and training controls, some
studies report that athletes had limited food intake for four hours prior to testing sessions, but
failed to report any control over exercise outside of the study.105 Furthermore, other studies do
not report any control over the diet or exercise outside of the study,109 yet others report dietary
control for 24 hours prior to testing and exercise limitations for 48 hours prior to testing.110
Training and food intake should be documented in the event that a study administers a cross-over
design and analysis should be performed to determine if there existed any difference prior to the
testing sessions. In the event that a difference is found in training or diet prior to the trials the
subjects data must be eliminate or test re-administered. An ideal research design should examine
the effect of supplementation in a manner which is consistent with the typical training practices
of athletes. These include hard and light days of training and familiarity with the standardized
guidelines prior to data collection. In addition, the diet should be what the athlete regularly
consumes for the duration of the study with controlled intake 12-24 hours prior to the exercise
trial. Furthermore, this method could in turn promote accurate record keeping among the
athletes in the study by allowing them to train without restrictions, as long as they train similarly
prior to all testing and experiment protocols. This method does include some guidelines, such as
only light exercise 48 hours prior to testing and refraining from exercise 24 hours prior to testing.
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Another limitation of these studies is the testing protocol. Although one commonly used method
to measure alterations in performance is cycling until exhaustion at a pre-determined intensity
level,110, 109, 105 this method is not appropriate for practical application in athletes.122 Exercise
time-to-fatigue is a poor measure for the analysis of cycling performance because the athlete
very rarely engages in this type of activity. However, fixed distance time trials closely simulate
training practices and/or racing events.58 Overall, it is difficult to compare data collected on
supplement studies because the protocols between studies vary for recalling exercise and diet
prior to testing and inappropriate performance protocols, like exercise to exhaustion.
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ABSTRACT
PURPOSE: To determine if 5 days of antioxidant supplementation coupled with a pre-ride
antioxidant/energy supplement improves cycling performance or reduces oxidative stress in
trained cyclists.
METHODS: Eight well-trained cyclists participated in a double-blind cross-over placebocontrolled study. Maximal oxygen consumption (VO2Max), peak power output (WMax) and total
work during a 15-minute time trial were determined. Subjects consumed an antioxidant
supplement (S) or a placebo (P) for 5 days before each trial and a pre-exercise supplement or
isocaloric placebo (4 kcal·kg-1) 45 minutes before each trial. Subjects performed an endurance
ride of 90 minutes followed immediately by a time trial requiring accumulation of total work
equal to the initial time trial.
RESULTS: The GSH:GSSG ratio remained constant prior to both experimental trials, while
resting total GSH concentrations exhibited a main effect (p = 0.038) in response to step-one of
the supplement protocol for basal (S: 1020.2 ± 135.8 µmol·L-1; P: 1000.2 ± 252.9 µmol·L-1) vs.
pre-endurance (S: 979.2 ± 155.1 µmol·L-1; P: 867.3 ± 231.2 µmol·L-1). During the endurance
ride, no differences were observed in average power (S: 224.0 ± 36.5 W; P: 219.1 ± 19.2 W),
oxygen consumption (S: 2.8 ± 0.4 L·min-1; P: 2.8 ± 0.4 L·min-1), heart rate (S: 148.4 ± 3.5
beats·min-1; P: 146.3 ± 4.5 beats·min-1), or GSH:GSSG ratio (S: 1.4 ± 0.7; P: 1.4 ± 0.9). During
the time trial tests, supplementation did not lead to any differences between average power (S:
303.6 ± 59.2 W; P: 306.1 ± 47.0 W), oxygen consumption (S: 3.5 ± 0.4 L·min-1; P: 3.3 ± 0.6
L·min-1), heart rate (S: 171.1 ± 6.5 beats·min-1; P: 170.3 ± 3.5 beats·min-1), or GSH:GSSG ratio
(S: 1.1 ± 0.6; P: 0.9 ± 0.7).
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CONCLUSION: Consuming an antioxidant supplement for 5 days coupled with a pre-exercise
antioxidant/energy supplement does not result in significant improvements in cycling
performance. However, the multiple-step supplementation may attenuate oxidative stress during
the cycling bout when compared to a placebo, possibly due to the maintenance of glutathione
levels.
Key Words: Bicycling/physiology, Energy Metabolism, Sports/physiology, Physical
Endurance/physiology, Oxidative Stress, Glutathione/blood
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INTRODUCTION
Competitive endurance athletes routinely engage in high intensity exercise during competition
(20). During an individual time trial, competitive cyclists spend an average of 20 minutes at
>90% maximal oxygen consumption (VO2Max) (20). The analysis of cross-country mountain
bike competitions reveals similar intensities as during competitive road cycling time trials.
Competitive cross-country mountain cyclists averaged 90% of maximal heart rate (HRMax) for 5
cross-country races that averaged 147 minutes (36).
In order to meet this work demand, a constant supply of energy to the working muscles must
be provided to maintain performance during high intensity aerobic exercise (39, 48). The
metabolic processes in the mitochondria result in the formation of free radicals and other reactive
oxygen species (31), which subsequently leads to the formation of reactive nitrogen species (84).
Antioxidants quench free radicals and reactive oxygen and nitrogen species, thereby reducing the
severity of oxidative stress (24). Oxidative stress occurs as a result of an imbalance between
reactive oxygen and nitrogen species and the antioxidant defense system (41).
The accumulation of reactive oxygen and nitrogen species can occur during high-intensity
exercise (25) leading to oxidative stress (42), oxidative red blood cell damage (75, 79), and
oxidative muscle damage (27, 67). Markers of muscle damage are shown to increase after
prolonged high-intensity cycling (27, 72, 73), and this oxidative damage may result in a decrease
in endurance performance due to muscle tissue loss and decreased capacity to transport oxygen.
The accumulation of oxidative damage is relative to the production of reactive oxygen and
nitrogen species (41) and the collective success of the antioxidant defense and muscle repair
systems (65).
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Recent studies have examined the effect of various dietary supplements on their ability to
enhance endurance performance (53), alter fuel metabolism (22, 57), decrease markers of
oxidative stress (54, 71), and decrease markers of post-exercise muscle damage (27, 65). These
dietary supplements include carbohydrate (39, 48), protein (51, 73, 81), arginine (1, 57),
carnitine (8), aspartate (1), tartrate (8), retinol, ascorbic acid, and α-tocopherol (2, 11, 12, 54, 62,
75), selenium (65, 77), allopurinol (27), Siberian ginseng (19), and reduced glutathione (71).
Most of these supplements have required long-term (~ 4 weeks) use to provide the desired
effects (2, 12, 27, 53), and most have been studied independently of one another (11, 27, 57, 62,
77).
It has been suggested that because most of these supplements work synergistically, they
should be consumed in combination as an antioxidant energy substrate cocktail, rather than
independently (74). Thus, supplementation with antioxidant energy substrate cocktails has also
been evaluated in regards to providing ergogenic effects (53, 78). There is evidence that the
consumption of an antioxidant energy substrate cocktail for 6 weeks increases endurance
performance (53), but the authors failed to identify any underlying mechanisms.
It has recently been proposed that long-term antioxidant supplementation may be detrimental
to cellular adaptations that lead to improvements in endurance capacity (26, 31). A number of
cellular signaling pathways respond to reactive oxygen and nitrogen species, which ultimately
contributes to improvements in endurance performance (43). Long-term supplementation may
prevent desirable adaptations in inducible antioxidants, limiting the adaptive capacity to deal
with reactive oxygen and nitrogen species (43).
Short-term antioxidant supplementation may be an alternative method that avoids the
problems associated with long-term antioxidant intervention. These protocols may lead to
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improvements in performance without interrupting cellular adaptations that occur as a result of
normal training. A few studies have investigated the effect of short term (≤14 days) antioxidant
supplementation on oxidative stress and performance (5, 33, 79). These supplementation
protocols varied in timing from 2 hours (5, 79) to 14 days (33) prior to exercise. A graded
cycling max test coupled with ascorbic acid supplementation taken 2 hours prior to the high
intensity aerobic exercise bout was shown to increase plasma ascorbic acid levels and decrease
oxidative stress at rest and in response to the exercise in healthy untrained subjects (5). This
indicates that short-term supplementation may therefore be beneficial in reducing oxidative
stress by attenuating uncontrolled production of reactive oxygen and nitrogen species that can
lead to an oxidative stress condition. An antioxidant energy substrate cocktail may provide
increased levels of protection beyond that of independently supplementing with only one
supplement type, but there currently exists no scientific literature evaluating this concept. Thus,
more research on the effects of short term antioxidant cocktail supplementation protocols on
cycling performance in trained athletes is warranted. Therefore, the purpose of this project was
to determine if a multiple step antioxidant nutritional supplement protocol which includes a 5
day antioxidant cocktail loading phase coupled with a pre-event antioxidant/energy beverage
increased performance, reduced markers of oxidative stress, or enhanced fuel metabolism during
a high-intensity cycle ergometry exercise test in trained competitive cyclists.

METHODS
Experimental Design. The present study was conducted using trained cyclists in a repeatedmeasures double-blinded crossover design to investigate the effects of a multiple-step
antioxidant energy supplement protocol. Oxygen consumption (VO2), heart rate, whole blood
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lactate, plasma glucose, and markers of oxidative stress were determined intermittently during
the experimental trials. The subjects were tested on four different occasions. The first testing
session was used to determine the cyclists’ anthropometrics, body composition, VO2Max, HRMax,
peak power output (WMax), and ventilatory threshold. The second session, which took place 5
days later, was used to determine the maximal amount of work the cyclists could perform during
a 15 minute time trial. The third and fourth sessions were the experimental conditions where the
cyclists were randomly assigned to either treatment or placebo conditions in a crossover design.
The third testing session took place 7 days after the second and the fourth testing session took
place 12 days after the third. Refer to Figure 1 for a summary of the testing timeline. Authors
controlled for time of day and pre-ride nutrition and training; subjects reported to the testing
laboratory and consumed a similar diet and engaged in similar training practices prior to each
testing session.
Subjects. Subjects were cyclists with at least two consecutive years of competitive cycling, no
current injuries or exercise restrictions, and who had not consumed antioxidant nutritional
supplements for the last thirty days prior to the initiation of the study. Eligibility was determined
using a health history questionnaire and a separate questionnaire specifically designed to obtain
information on cycling background and supplement use. Subjects provide informed consent and
received a description of events for the study. The West Virginia University Institutional
Review Board approved (#9999-16954) the study protocol statement including all forms and
procedures. A summary of subject characteristics are presented in table 1.
Preliminary Testing. Subjects refrained from intense training for 24 hours prior to all testing
procedures but were allowed to follow their usual exercise and competition patterns. Preliminary
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testing began with determination of body composition by air displacement using a BodPod (Life
Measurement, Inc., Concord, CA).
The same lab technician determined the cyclists racing bike measurements and reproduced
the identical cycling position on all testing bikes for all procedures during the study. The cyclist
performed a 10-15 minute warm-up at a self-selected intensity on a fixed-gear CycleOps 300PT
(CycleOps, Madison, WI) with the incorporation of two 30 second sprints, a modified version
previously used by Dumke et. al. (14). Subjects underwent a continuous incremental cycle test
(25 W/minute step increment every 1 minute, initial load 125 W) to exhaustion to determine
VO2Max, WMax, and ventilatory threshold on a electronically braked cycle ergometer (LODEExcalibur Sport, Electra Med Corp., Flint, MI) equipped with their own pedals (28). Oxygen
consumption was measured continuously by directing expired air to a MedGraphics CardioO2
system (Medical Graphics, St. Paul, MN) (14). Heart rates were monitored continuously using a
4-lead exercise ECG (Welch Allen, CardioPerfect, Skaneateles Falls, NY), and Borg rating of
perceived exertion (RPE) was documented for every stage (7). Cyclists maintained a cadence
between 80-110 revolutions per minute (rpm) throughout the test (20). Tests were terminated at
volitional exhaustion and the criteria for determination of a maximal exercise test, plateau in
VO2, 90% of age predicted HRMax, and respiratory exchange ratio (RER) ≥ 1.15, was used to
determine if the test was maximal (2). The ventilatory threshold was determined from the
VO2Max test by standard procedures (4).
Multiple Step Supplement Protocol. Subjects were randomized in a double blind fashion to
treatment or placebo upon entry into the study and later crossed-over to serve as their own
controls. During step-one of the supplement protocol, subjects were instructed to consume 4
capsules·day-1, 2 in the a.m. and 2 in the p.m., of treatment, antioxidant supplement (ProStandard
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Endurance®, AmeriSciences®, Houston, TX), or placebo for five days prior to the first
experimental trials. Capsules were identical in appearance and taste. See table 2 for a list of
ingredients in the treatment capsules and see table 3 for a list of ingredients in the placebo
capsule. In the case of a cyclist forgetting to consume the capsules at any given specified time
they were instructed to consume the missed capsules with the next regularly schedule dose. The
cyclist completed consumption of the capsules on the evening prior to the experimental trials and
all cyclist were able to consume all 20 capsules over the five day step-one loading phase with no
reported side effects. The cyclists returned an empty bag that previously contained the capsules
with a form containing their signature confirming consumption of the capsules (45). During this
five day period subjects completed a training log and dietary recall. During the crossover trial
subjects consumed a similar diet and performed a similar training load to the first trial, an
additional dietary recall and training log were analyzed and used to determine if discrepancies
existed prior to the next trial.
Following a 12 hour overnight fast, subjects consumed the second-step of the multiple step
supplement protocol, the morning of the experimental test rides. Upon arrival to the testing
facility, after body weight and a resting blood draw, subjects consumed 4 kcal/kg of body weight
of either a treatment, antioxidant/energy (ProStandard PreGame,® AmeriSciences®, Houston,
TX) beverage or an isocaloric placebo beverage dissolved in 0.281 fl.oz. of water per gram of
powder. The beverage was consumed in entirety a minimum of 45 minutes prior to the
commencement of cycling. The placebo and treatment beverage were identical in color and
taste, See table 3 for a list of ingredients in the placebo beverage and table 4 for a list of
ingredients in the treatment beverage. All cyclists were able to consume and maintain
consumption of the beverages with no side effects.
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After the cyclists completed the first supplement period they entered into a 7 day wash out
period (6). After this wash-out the cyclists crossed-over into the second supplement period.
Baseline Trial. At least 72 hours after the maximal test cyclists returned to the lab at 7:00 a.m.
for a familiarization ride on the stationary CycleOps 300PT equipped with their own pedals and
saddle. The PowerTap power meter (CycleOps, Madison, WI) in the rear hub of the CycleOps
300PT has previously been validated for submaximal endurance test (30). The cyclist used the
same warm-up method as previously described during the preliminary testing. The cyclists
began the time trial from a standing start and were instructed to complete as much work as
possible in 15 minutes. The cyclists had full control of their cadence and resistance during this
time trial. The total amount of work was recorded in kilojoules during the time trial. Heart rate,
VO2, and RPE were measured during the time trial using the same methods as during the VO2Max
test.
Dietary & Training Control. For 5 days prior to each experimental trial, subjects recorded
their dietary intake using a provided diet journal to document the food preparation method and
amount consumed. Each subject was provided with detailed instructions for measuring the food
and recording it into their 5-day dietary journal. The 5-day dietary recall prior to the first testing
session was then used as a menu for the 5 days prior to the second testing session. The subjects
were requested to eat foods as similar as possible to those consumed prior to the first testing
session. Another journal was filled out prior to the second testing session and reviewed prior to
initiation of the second test. If the diet was not found to be similar the testing session was
rescheduled or the subject was dropped from the study. This approach to dietary control was
modified from a previous version used by Kulik et. al. (47).
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Similarly, training was recorded for 5 days prior to the testing session using a training journal.
Subjects provided as much data as possible in the categories of time, average heart rate, average
power, type/style of workout, distance, speed, and course. Subjects were to refrain from intense
exercise 24 hours prior to each experimental test. The training journal filled out prior to the first
testing session was then used as a training plan for the week prior to the second testing session.
During the week prior to the second testing session another training journal was filled out. The
journal was reviewed prior to the second testing session and if not found to be similar to the first,
the subjects was rescheduled or dropped from the study.
Experimental Trials. Cyclists returned to the lab at 7:00 a.m. one week after the time trial for
the first of two experimental trials on the CycleOps 300PT. The equipment (i.e. pedals and
saddle) and settings on the CycleOps were identical to previous settings used by each cyclist
during the time trial. The cyclists performed a 90 min endurance ride at a work load that
represented a heart rate of five beats below their ventilatory threshold. During the endurance
ride cyclists’ heart rate was measured continuously and RER, VO2, and RPE were measured for
5 min continuously in 15 min increments, using a modified version of the method of McAnulty
et. al. (56). After the endurance ride, cyclists began a high intensity self-paced time trial from a
standing start. During the time trial cyclists completed the same amount of work that was
achieved during the time trial as quickly as possible. The cyclist had full control of their cadence
and resistance during the time trial. The time to complete the amount of work was recorded.
During the time trial cyclists’ heart rate, VO2, and RPE were measured using the same methods
as during the VO2Max test. After a 7 day wash-out and another 5 day loading phase cyclists
returned to the lab for their second endurance ride and second time trial in identical conditions to
which the first endurance ride and time trial were performed.
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Sample Collection. All samples were collected from the antecubital vein in the forearm into
EDTA vacutainer® blood collection tubes (Becton, Dickinson and Company, Franklin Lakes,
NJ) by trained phlebotomists. Hematocrit was determined and samples were further aliquoted
into appropriately labeled microcentrifuge tubes for determination of GSH, GSSG, and lactate
concentrations. Remaining whole blood was centrifuged (1000 g) for 15 minutes and plasma
was aliquoted into appropriately labeled centrifuge tubes for determination of blood glucose and
nitrotryosine. All aliquoted samples were immediately frozen at -80°C. A blood volume of 18
mL was collected at each sampling point. Prior to the supplement protocol, a resting baseline
blood sample was drawn after 15 min of rest. Another resting sample was drawn after the 5 day
step-one supplement loading phase prior to the consumption of the second-step in the
supplement protocol on the morning of the endurance ride in similar conditions to the initial
resting blood draw. Exercising samples were drawn immediately after the endurance ride and
time trial. After a minimum 7-day wash-out period, another baseline sample was drawn at the
point of crossing-over to the other treatment and a resting sample prior to the endurance ride, a
post endurance ride sample, and a post time trial sample were all drawn in similar conditions to
the first testing session.

66

ANALYTICAL METHODS
Dietary and Training. Dietary analyses for total calories, fats, carbohydrates, and proteins were
performed using Food Processor Plus for Windows version 6.05 (ESHA Research, Salem, OR).
Food Processor Plus was utilized because it has been shown to have a low percentage (0.03%) of
missing information (49). Training analysis between groups was performed by totaling the
number of training sessions. The number of training sessions was the only uniform method used
to document training by all subjects.
Hematocrit. Whole blood was immediately collected from EDTA tubes into microcapillary
tubes and hematocrit was determined according to standard procedures. Hematocrit changes
were used to estimate plasma volume shift for correcting lactate, glucose, glutathione, and
nitrotyrosine concentrations (80).
Blood Lactate. Whole blood was immediately aliquoted from EDTA tubes into pre-chilled
lactate preservative microcentrifuge tubes (YSI Life Sciences, Inc., Yellow Springs, OH) and
used for the determination of lactate concentrations. Preservative tubes were immediately
vortexed, frozen, and stored at -80°C until analysis was performed. Lactate analysis was
performed in triplicate on a YSI Sport lactate analyzer. The analyzer was calibrated with known
concentrations of lactate according to standard procedures and all samples were run in triplicate
and averaged. If a value was found to be an outlier it was eliminated and the two remaining
values were averaged. The raw data was corrected for plasma volume shifts during the
experimental trials. Reliability was considered high as can be seen by the coefficient of variance
and intraclass correlations, 1.2% and 0.99, respectfully.
Plasma Glucose. For measurement of plasma glucose, whole blood was centrifuged at 1000 g
for 10 min. Plasma was aliquoted into pre-chilled 1ml microcentrifuge tubes, immediately
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frozen and stored at -80°C until analysis was performed. Plasma glucose concentrations were
determined using standard ELISA (Glucose Assay Kit: GAGO20, Sigma, Saint Louis, MO)
procedures and all samples were run in triplicate. The raw data was corrected for plasma volume
shifts during the experimental trials. Reliability was considered high as can be seen by the
coefficient of variance and intraclass correlations, 4.9% and 0.94, respectfully.
Total-body fuel oxidation. Total-body rates of fat and CHO oxidation (g·min-1) were calculated
during the cycling experimental test from the rate of CO2 production (VCO2) and VO2 by using
the nonprotein respiratory exchange ratio values according to the following equations (22):
Fat oxidation (g·min-1) = [1.695 x VO2 (L·min-1)] – [7.01 x VCO2 (L·min-1)]
CHO oxidation (g·min-1) = [4.585 x VCO2 (L·min-1)] – [3.226 x VO2 (L·min-1)]
Blood Glutathione. Whole blood was used for determination of GSH and GSSG. Whole blood
was aliquoted into pre-chilled microcentrifuge tubes, immediately frozen, and stored at -80°C
until GSH analysis. To prevent further oxidation from occurring in GSSG whole blood samples,
10 µl of the scavenger 1-methyl-2-vinylpyridinium trifluoromethanesulfonate (M2VP) was
placed into pre-chilled microcentrifuge tubes prior to the addition of 100 µl of the whole blood
sample. GSSG samples were immediately frozen and stored at -80°C until analysis was
performed.
Analysis of GSH and GSSG was performed in triplicate using an assay kit (GSH/GSSG-412
assay: Calorimetric determination of reduced and oxidized glutathione, Oxis Research®,
Portland, OR, USA) according to standard procedures (18). The raw data was corrected for
plasma volume shifts during the experimental trials. Reliability was considered high as can be
seen by the coefficient of variance and intraclass correlations, 5.0% and 0.99, respectfully.
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Plasma Nitrotyrosine.

Blood plasma was used for determination of nitrotyrosine

concentrations. Whole blood was centrifuged at 1000 g for 10 min, the supernatant, plasma, was
collected without disruption of the white buffy layer of leukocytes. The plasma was aliquoted
into pre-chilled 1ml microcentrifuge tubes, immediately frozen and stored at -80°C until analysis
was performed.
Analysis of nitrotyrosine was performed in triplicate using an assay kit (Hbt Nitrotyrosine
ELISA kit for calorimetric determination, Cell Sciences®, Canton, MA, USA) according to
standard procedures. The raw data was corrected for plasma volume shifts during the
experimental trials. Coefficient of variance and intraclass correlations were 10.6% and 0.99,
respectfully.

STATISTICS
Paired comparisons were utilized in the analysis of dietary and training log data collected
during step 1 of the supplement protocol, which encompassed the 5 day supplement period.
Additionally, a 2 x 2 (treatment x time) repeated measures analysis of variance (ANOVA) was
utilized in order to determine the differences between the markers of oxidative stress and antioxidant defenses in response to the 5 day supplement protocol. Follow-up paired comparisons
were utilized in conjunction with a Holm’s Bonferroni procedure for controlling type I errors
when significant F values (p ≤ 0.05) were determined (34). A 2 x 3 (treatment x time) repeated
measures ANOVA were performed to determine significant differences between the 2 treatment
trials for lactate, glucose, and markers of oxidative stress at the pre-endurance ride, immediately
post endurance ride, and immediately post time trial. When significant F values were determined
(p ≤ 0.05), paired comparisons were used in conjunction with a Holm’s Bonferroni method for
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controlling type I errors (34). All data are reported as means ± standard deviations. Statistical
significance was set at the p ≤ 0.05 level of confidence. All analyses were performed with SPSS
14.0 (SPSS, Chicago, IL).

RESULTS
Nutritional intake between the two tests was not significantly different with calories (S: 3407.0 ±
1112.2 kcal; P: 3432.4 ± 1115.8 kcal), fats (S: 127.7 ± 47.6 g; P: 130.7 ± 47.6), carbohydrates
(S: 442.3 ± 171.7 g; P: 437.6 ± 164.5 g), or proteins (S: 126.0 ± 48.1 g; P: 123.8 ± 46.3 g). The
number of training sessions between the two tests was not significantly different (S: 5.6 ± 5.1 #;
P: 5.4 ± 5.1 #).
Performance. During the controlled endurance ride portion of the cycling protocol there was no
significant difference between absolute or relative indicators of performance (Table 5) or RPE
(S: 12.8 ± 0.9; P: 12.5 ± 0.9). Economy during the endurance ride significantly increased as the
duration increased for in-trial comparisons, 30-min vs. 60-min (S: 68.7 ± 15.3 vs. 82.6 ± 16.3
W·L-1·min-1; p = 0.001, η2 = 0.83; P: 69.5 ± 17.5 vs. 85.1 ± 16.1 W·L-1·min-1; p = 0.003, η2 =
0.73), and 30-min vs. 90-min (S: 68.7 ± 15.3 vs. 84.2 ± 12.9 W·L-1·min-1; p = 0.001, η2 = 0.83; P:
69.5 ± 17.5 vs. 86.5 ± 14.3 W·L-1·min-1; p = 0.003, η2 = 0.20) (Figure 4). During the time trial
portion of the cycling protocol there were no significant differences between trials in the absolute
or relative indicators of performance (Table 5), time (Figure 2), or RPE (S: 17.1 ± 1.3; P: 16.7 ±
1.9). In relation to relative power some cyclists’ performance increased during treatment while
other cyclists’ relative power was in favor of the placebo (Figure 3). Economy during the time
trial significantly decreased as the duration increased for in-trial comparisons, 5-min vs. 10-min
(S: 94.9 ± 14.0 vs. 81.5 ± 11.8 W·L-1·min-1; p = 0.001, η2 = 0.81; P: 100.1 ± 15.0 vs. 85.0 ± 11.3
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W·L-1·min-1; p = 0.001, η2 = 0.83), and 5-min vs. 15-min (S: 94.9 ± 14.0 vs. 83.6 ± 12.6 W·L1

·min-1; p = 0.002, η2 = 0.75; P: 100.1 ± 15.0 vs. 87.9 ± 9.9 W·L-1·min-1; p = 0.002, η2 = 0.77)

(Figure 5).
Lactate. Lactate concentrations were significantly different for in-trial comparisons
demonstrating a time effect, pre-endurance ride vs. post endurance ride (S: 0.65 ± 0.11 vs. 1.16 ±
0.23 mmol·L-1; p ≤ 0.001, η2 = 0.86), post endurance ride vs. post time trial (S: 1.16 ± 0.23 vs.
4.52 ± 1.71 mmol·L-1; p = 0.001, η2 = 0.82) and (P: 0.83 ± 0.24 vs. 5.42 ± 1.97 mmol·L-1; p ≤
0.001, η2 = 0.87), pre-endurance ride vs. post time trial (S: 0.65 ± 0.11 vs. 4.52 ± 1.71 mmol·L-1;
p ≤ 0.001, η2 = 0.85) and (P: 0.89 ± 0.29 vs. 5.42 ± 1.97 mmol·L-1; p ≤ 0.001, η2 =0 .87) (Figure
6). There was no significant difference for in-trial comparison of pre-endurance ride vs. post
endurance ride (P: 0.89 ± 0.29 vs. 0.83 ± 0.24 mmol·L-1; p = 0.643, η2 = 0.03) (Figure 6).
Glucose. Plasma glucose concentration demonstrated a time-by-treatment interaction (p = 0.004,
η2 = 0.92) when comparing basal (S: 4.76 ± 0.72 mmol·L-1; P: 4.51 ± 0.39 mmol·L-1) vs. preendurance ride (S: 4.07 ± 0.66 mmol·L-1; P: 4.70 ± 0.62 mmol·L-1) vs. post endurance ride (S:
4.83 ± 0.64 mmol·L-1; P: 3.56 ± 0.67 mmol·L-1) vs. post time trial (S: 4.29 ± 0.64 mmol·L-1; P
4.78 ± 1.05 mmol·L-1) values.
Total Body Fuel Oxidation. CHO oxidation rates displayed a significant time effect for
endurance ride vs. time trial when analyzed by 2x3 ANOVA (S: 3.11 ± 0.37 vs. 5.25 ± 0.62
g·min-1; P: 2.96 ± 0.57 vs. 4.90 ± 1.42 g·min-1; p ≤ 0.001, η2 = 0.88). However, post-hoc
analyses were not statistically different (S: 3.11 ± 0.37 vs. 5.25 ± 0.62 g·min-1; p = 0.069, η2 =
0.96; P: 2.96 ± 0.57 vs. 4.90 ± 1.42 g·min-1; p = 0.73, η2 = 0.73). Fat oxidation rates displayed a
significant time effect for endurance ride vs. time trial when analyzed by 2x3 ANOVA (S: 0.26 ±
0.13 vs. -0.20 ± 0.15 g·min-1; P: 0.27 ± 0.20 vs. -0.17 ± 0.31 g·min-1; p ≤ 0.001, η2 = 0.857).
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However, post-hoc analysis were not statistically different (S: 0.26 ± 0.13 vs. -0.20 ± 0.15 g·min1

; p = 0.15, η2 = 0.93; P: 0.27 ± 0.20 vs. -0.17 ± 0.31 g·min-1; p = 0.69, η2 = 0.69).

Glutathione. Resting total GSH concentrations exhibited a main effect (p = 0.038, η2 = 0.04) in
response to step-one of the supplement protocol when comparing basal (S: 1020.2 ± 135.8 µmol1

; P: 1000.2 ± 252.9 µmol-1) to pre-endurance ride (S: 979.2 ± 155.1 µmol-1; P: 867.3 ± 231.2

µmol-1). Resting GSSG concentrations were not significantly different (p = 0.076, η2 = 0.38)
when comparing basal (S: 311.7 ± 71.6 µmol-1; P: 304.1 ± 37.4 µmol-1) to pre-endurance ride
(S: 292.1 ± 53.8 µmol-1; P: 274.0 ± 73.4 µmol-1). The GSH:GSSG ratio was not significantly
different (p = 0.893, η2 = 0.003) when comparing basal (S: 1.4 ± 0.7; P: 1.3 ± 0.8) to preendurance ride (S: 1.4 ± 0.7; P: 1.2 ± 0.6) (Figure 7).
Total glutathione concentrations were not significantly different (p = 0.070, η2 = 0.59) in
response to the cycling protocol when comparing pre-endurance ride (S: 979.2 ± 155.1 µmol-1;
P: 867.3 ± 231.2 µmol-1) vs. post endurance ride (S: 953.1 ± 112.7 µmol-1; P: 971.1 ± 191.1
µmol-1) vs. post time trial (S: 886.0 ± 146.8 µmol-1; P: 921.2 ± 185.7 µmol-1). The
concentrations of GSSG were not significantly different (p = 0.076, η2 = 0.58) in response to the
cycling protocol when comparing pre-endurance ride (S: 292.1 ± 53.8 µmol-1; P: 274.0 ± 73.4
µmol-1) vs. post endurance ride (S: 293.0 ± 61.6 µmol-1; P: 298.8 ± 74.6 µmol-1) vs. post time
trial (S: 292.3 ± 60.1 µmol-1; P: 330.4 ± 86.2 µmol-1). The GSH:GSSG approached significance
(p = 0.057, η2 = 0.62) for a treatment-by-time effect when comparing pre-endurance ride (S: 1.4
± 0.7; P: 1.2 ± 0.6) vs. post endurance ride (S: 1.4 ± 0.7; P: 1.4 ± 0.9) vs. post time trial (S: 1.1 ±
0.6, P: 0.9 ± 0.7) (Figure 7).
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Nitrotyrosine. Nitrotyrosine concentrations were not significantly different (p = 0.445, η2 =
0.10) between pre-endurance ride (S: 51.65 ± 72.41 nmol·L-1; P: 47.99 ± 60.36 nmol·L-1) and
post time trial (S: 75.05 ± 124.00 nmol·L-1; P: 83.96 ± 151.11 nmol·L-1).

DISCUSSION
The present study was designed to test the effects of short-term antioxidant supplementation
on prolonged sub-maximal cycling, high-intensity cycling performance, and biochemical
markers of oxidative stress while cyclists participated in their typical training and racing
schedules. Peak aerobic power values, cycling economy, and racing experience classify the
cyclists as well-trained (Table 1) (40). Cyclists of this caliber who regularly engage in highintensity exercise are expected to benefit from antioxidant/nutritional supplementation (72).
However, the cyclists in the present study did not demonstrate any performance gains after shortterm supplementation with a multiple-step antioxidant nutritional cocktail.
The main finding of this study was that 5 days of antioxidant supplementation and a preexercise antioxidant/energy supplement approached significance for a treatment-by-time effect
on the GSH:GSSG ratio (Figure 7). The supplementation attenuated the decrease in the ratio that
was observed with the placebo in response to the time trial. However, the supplement protocol
did not result in any improvements in cycling performance when compared to the placebo
(Tables 5, Figures 2, 3, 4, and 5).
The performance testing protocol used in the present study has been validated for measuring
endurance performance enhancement due to diet interventions (38). The high-intensity portion
of the protocol consisted of a maximal self-paced time trial in which the cyclists averaged
approximately 85% VO2Max and 90% HRMax (Table 5). This intensity is similar to what cyclists
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would engage in during a road time trial or mountain bike competition (36, 63). Furthermore,
the high-intensity nature of the time trial is supported by the lactate data (Figure 5). Lactate
concentrations increased significantly during the time trial compared to the endurance ride for
both treatment and placebo trials, and the cyclists achieved lactate concentrations above 4
mmol·L-1 during the time trial, which is similar to data collected on other trained cyclists (14).
Thus, we can conclude that similar race intensities were reproduced in the testing scenario.
The cyclists’ economy for both the endurance ride and time trial (Tables 4 and 5)
demonstrated a time effect for both treatment and placebo trials. After an initial increase, the
cyclists’ economy leveled-off during the later portion of the endurance ride. This initial
improvement in cycling economy was most likely due to a delay in aerobic enzymatic activity at
the onset of the cycling, while the decrease that occurred during the time trial was most likely
due to fatigue that results from cycling at a high-intensity. Typical ratings of economy for
trained cyclists are reported to be higher than 72 W·L-1·min-1 (40), and economy values for
highly-competitive cyclists have been reported at 85 W·L-1·min-1 (50). Cyclists in the present
study reached greater than 81 W·L-1·min-1 during later portions of the endurance ride and time
trial.
Other similarities with cycling literature are the blood glucose concentrations and CHO
oxidation rates of the cyclists. Blood glucose levels ranged from 3.56-4.78 mmol·L-1 throughout
the testing protocol. While this seems quite low, the cyclists arrived at the laboratory in a fasted
state and ingested only 4 kcal·kg body weight-1 prior to the endurance ride. These values are
similar to those reported by Dumke et al. (15), which ranged from 3.5-5.2 mmol·L-1. Total-body
rates of CHO oxidation were calculated from the RER and, as expected, increased significantly

74

during the time trial. The values during the endurance ride are also in line with values reported
from other sources when measured during an endurance cycling bout (10, 22, 32).
One aim of this study was to determine if a multiple-step antioxidant nutritional supplement
alters markers of oxidative stress. The non-enzymatic antioxidant reduced glutathione has the
ability to protect cells from the toxic effects of reactive oxygen species and related products (58).
It is also used by glutathione peroxidase to neutralize hydrogen peroxide, resulting in the
formation of oxidized glutathione (58), and it enhances the function of other exogenous
antioxidants, such as ascorbic acid and α-tocopherol (29, 55). Blood glutathione oxidation is a
consistent determining marker of oxidative stress (74), as a decrease in the reduced
glutathione/oxidized glutathione ratio and total glutathione concentration is routinely shown in
the blood of exercising humans (17, 18, 23, 46, 77), while the oxidized glutathione/total
glutathione ratio increases (9, 71).
Blood reduced glutathione concentrations are generally between 800-2000 µmol·L-1 (17, 18,
44), and oxidized glutathione concentrations vary depending on free-radical induced oxidative
stress but have been found to be between 2.0-800 µmol·L-1 (17, 18, 44). Higher reduced
glutathione concentrations are found during rest, and higher oxidized glutathione concentration
found during exercise. Concentrations also vary depending on the subject’s level of training (46)
and nutritional intake (37, 44), as well as in response to different types of exercise durations (13,
16, 23) and intensities (21, 35), with greater intensities of exercise resulting in greater decreases
in reduced glutathione (21). Training increases the basal reduced glutathione concentration in
the blood (17), thereby providing increased protection against oxidative species during exercise.
Our data indicate that the use of an all-natural antioxidant for a 5 day loading phase also has the
potential to maintain basal total GSH levels during a competitive season (p = 0.038). Since total

75

GSH is a measure of both GSH and GSSG, the finding that there was not a significant difference
in the concentration of GSSG suggests that GSH levels were increased, which could potentially
provide an extra level of protection against oxidative stress during exercise.
Furthermore, it is suggested that reactions between reactive oxygen species and nitric oxide
result in the formation of nitrogen oxide intermediates, such as peroxynitrite, which nitrate
proteins (82). Tyrosine residues found on proteins are susceptible to nitration by peroxynitrite,
resulting in alteration of the physiological functions of these proteins and ultimately degradation
(76). More specifically, peroxynitrite reacts directly with thiols, such as glutathione, and
hemoproteins (66, 60). The product of tyrosine nitration, nitrotyrosine, can therefore also be
used as a marker of oxidative stress (3, 82) and provide an indication of the potential for
oxidation of thiols and hemoproteins. However, our data indicated no significant changes in the
nitrotyrosine concentrations with exercise.
The non-significant changes in the glutathione antioxidant system and nitrotyrosine
concentrations indicate that a 90-min cycling exercise at a heart rate of five beats below the
ventilatory threshold, approximately 65% VO2Max, did not appear to induce oxidative stress in
trained cyclists, although reductions in the GSH:GSSG ratio did occur during the time trial. The
findings during the preload portion of the cycling protocol are inconsistent with the observations
from other studies which have used long-duration cycling exercise as a means to induce
oxidative stress as indicated by glutathione status (23, 83).
A potential reason for the discrepancy in our oxidative stress results could be due to sample
collection procedures. While both Gohil et al. (23) and Viguie et al. (83) also reported no change
in total GSH levels, they reported increases in GSSG and decreases in GSH. These changes
could have occurred during sample collection, where it is possible that GSH was rapidly
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oxidized to form GSSG. The methods used in our study involved the use of a fast-acting
scavenger agent M2VP to neutralize any free radicals present at the time of sample collection
and prevent any further in vitro oxidation. Therefore, the discrepancy between past and present
data is most likely due to the presence of the scavenger in the collection procedure. The
concentrations found in our study are in line with those reported by others who have also used
M2VP (18, 17).
In addition, data published after the completion of this study suggests that the best time point
for sampling blood alterations in the glutathione antioxidant system is 2 hours after the cessation
of exercise (59), indicating that our immediately post-exercise sampling point may have
potentially been too early to examine the greatest alterations in the glutathione system.
However, the study was performed on untrained subjects using an exhaustive treadmill protocol,
while our study examined trained cyclists. In addition, another study demonstrated that
alterations in the glutathione antioxidant system appear to be diminished 30 minutes after the
cessation of exercise in trained cyclists and runners (23). Therefore, the immediate post exercise
time point appears to be appropriate with trained athletes such as those in the present study.
To our knowledge, this was the first attempt to use nitrotyrosine as an indicator of oxidative
stress in response to cycling. Other studies have successfully used similar cycling protocols to
induce oxidative stress on other indices such as protein carbonyls and plasma 8-OHdg levels
(61). Nitrotyrosine levels have been shown to increase significantly in response to long-duration
running during a consecutive four-day super-marathon totaling 328 km (67). This rise in protein
nitration indicates the occurrence of oxidative stress to proteins in well-trained endurance
athletes. While one might argue that an event this extreme may not relate to usual competitions
in which most endurance athletes engage, the levels of serum nitrotyrosine increased after the
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first day, which consisted of 93 km of running, and remained at that level for the duration of the
competition (67). In the present study, the nitrotyrosine levels increased in response to cycling,
but the subject pool presented with a large individual variation in the levels of resting and
exercising nitrotyrosine, which may have masked any significant alterations that may have been
present. This individual difference is most likely due to the principle that the accumulation of
oxidative damage is relative to the collective success of the antioxidant and muscle repair
systems (68), training status (54, 64), and intensity of the exercise (35).
This study was designed to provide insight into whether or not short-term antioxidant
supplementation is capable of increasing performance by decreasing oxidative stress in trained
cyclists in response to a high-intensity cycling test during a competitive cycling season. To
directly answer this question, a series of events must occur. First, the exercise protocol must
disturb the balance of antioxidants/oxidants to establish a state of oxidative stress in the system.
Second, the biological markers used to asses the stress must be sensitive enough to detect any
alterations. Third, the subjects must present with increased performance under a state of reduced
stress while consuming the treatment. These series of events would lead to a positive correlation
that could suggest that short-term antioxidant supplementation may lead to increases in cycling
performance. Without the occurrence of all of these events, it is difficult to determine if there is
any benefit to consuming an antioxidant supplement for a short loading phase prior to highlyaerobic competitions such as competitive cycling.
Perhaps a more demanding protocol such as 3 consecutive days of high-intensity cycling that
closely resembles a stage race could increase oxidative stress levels and subsequently result in
greater levels of fatigue. Such a protocol has been used to examine the effects of a beverage
containing carbohydrate, protein, and antioxidants over 2 days of consecutive cycling, but while
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levels of creatine kinase were decreased, the authors were unable to show an increase in
performance and failed to examine any indicators of oxidative stress (70). Furthermore, during
the Tour de France, the administration of allopurinol, an inhibitor of the free radical-generating
enzyme xanthine oxidase, did attenuate increases in the marker of lipid peroxidation
malondialdehyde but did not result in any increases in performance (27). These data indicate
that a multiple-day protocol induces muscle damage and oxidative damage, respectively;
therefore, a multiple day protocol could be useful in determining the effects of short-term
antioxidant supplementation.
In summary, although this study does not indicate that a short-term multiple-step antioxidant
nutritional supplement protocol results in improved cycling performance, according to the data
collected on the glutathione antioxidant system it does provide some level of protection against
oxidative stress. Even though some adaptation of the antioxidant systems can occur (69), the
adaptations may not be adequate to prevent oxidative damage in some athletes (65) or to improve
performance. A nutritional supplement that provides antioxidants and energy could be ideal for
some endurance athletes (52, 41), and research should continue to evaluate its effects on
oxidative stress and performance using novel antioxidant supplements.
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Table 1. Subject Characteristics
Variable
Mean ±
SD
Range
Age (years)
28.9 ±
7.2
(22-44)
Body Mass (kg)
77.5 ±
7.0
(69.5-88.2)
Height (cm)
178.1 ±
6.3
(171.8-191.0)
Racing Experience (years)
9.9 ±
4.9
(3-20)
Max heart rate (b·min-1)
186.5 ±
7.4
(174-198)
Body fat (%)
16.4 ±
7.4
(3.3-24.7)
VO2max (ml·kg-1·min-1)
55.0 ±
5.5
(49.0-65.3)
VO2max (L·min-1)
4.2 ±
0.3
(3.9-4.7)
Max power output (W)
400.7 ± 30.7
(350.0-443.8)
5.2 ±
0.7
(4.3-6.2)
Max power output (W·kg-1)
Data are presented as mean ± SD; range is in parentheses; N=8. Max =
maximum.
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Table 2. Step-One Treatment Ingredients
Serving Size: 4 Vegetarian Capsules
Vitamin C (as ascorbic acid)
Thiamine (vitamin B1) (as thiamine mononitrate)
Riboflavin (vitamin B2)
Niacin (as inositol hexanicotinate)
Vitamin B6 (as pyridoxine hydrochloride)
Folate (as folic acid)
Vitamin B12 (as cyanocobalamin)
Biotin
Pantothenic Acid (as d-calcium pentothenate)
Calcium (from mineralized seaweed)
Iron (as ferrous bisglycinate)
Zinc (as zinc monomethionine)
Selenium (as selenomethionine)
Chromium (as chromium picolinate)
Endurance Proprietary Blend
Bromelain, Hawthorne Extract (berry), Mullein (leaf),
Quercetin, Eleuthero Extract (root), American Ginseng
Extract (root), Cordyceps Extract (mushroom), Devil’s
Claw Extract (root), Milk Thistle Extract (seed), Nettle
Extract (root), Turmeric Extract (root), Prickly Ash (bark),
Cayenne Extract (fruit), Choline (as choline bitartrate),
Astragalus Extract (root), Panax Ginseng Extract (root),
PABA (as para-aminobenzoic acid), Bioperine® Pepper
Extract (fruit), Astaxanthin, Vanadium (as BGOV bisglycinato-oxo-vanadium)
* % Daily Value not established
OTHER INGREDIENTS:
Cellulose, Maltodextrin, Silicon Dioxide, Magnesium Stearate
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Amount per
Serving
100 mg
25 mg
25 mg
75 mg
25 mg
100 mcg
200 mcg
20 mcg
25 mg
100 mg
9 mg
10 mg
70 mcg
120 mcg
1,107 mg

% Daily Value
167%
1667%
1471%
375%
1250%
25%
3333%
7%
250%
10%
50%
67%
100%
100%
*

Table 3. Step-One and Step-Two Placebo Ingredients
Product (serving size)
Capsules
Beverage (24.5 g)
--100
Calories
Total Carbohydrate (g)
--25
*
**
Listed Ingredients
* microcrystalline cellulose, manntitol, FDC yellow #5 lake, FDC yellow #6 lake, FDC
blue #2 lake, magnesium stearate, and silicon dioxide
** maltodextrin, dextrose, non-fat dry milk, spirulina, natural and artificial flavors, and
stevia extract
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Table 4. Step-Two Treatment Ingredients
Serving Size: 1 packet (24.5 g)
Amount
per Serving
100
5
0.5 g
< 5 mg
14 g
5g
4g
9g
80 mg
21.2 g

Calories
Calories from Fat
Total Fat
Cholesterol
Total Carbohydrate
Dietary Fiber
Sugars
Protein
Sodium
PreGame Proprietary Blend:
* % Daily Value not established
† Percent Daily Values are based on a 2,000 calorie diet.
Other Ingredients:
Non Fat Dry Milk, Natural Flavors, Stevia Leaf Extract
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% Daily Value

1% †
1% †
5% †
20% †
*
3%
*

Table 5. Performance Data
Variable
Treatment ER
Mean ±
SD
Relative Performance
Average VO2
36.5 ±
3.2
Average PWR
2.8 ±
0.4
% VO2max
66.7 ±
7.9

Placebo ER
Mean ±
SD
35.7 ±
2.8 ±
65.4 ±

4.5
0.4
9.2

t-test

Treatment TT
Mean ±
SD

p

η2

0.35
0.68
0.34

0.12
0.03
0.12

45.3 ±
3.9 ±
82.6 ±

3.5
0.8
5.8

Placebo TT
Mean ±
SD
42.6 ±
4.0 ±
78.1 ±

6.0
0.6
12.8

t-test
P

η2

0.19
0.84
0.17

0.01
0.01
0.23

Absolute Performance
2.8 ±
0.4
2.8 ±
0.4 0.39 0.11
3.5 ±
0.4
3.3 ±
0.6 0.21
0.01
Average VO2
Average HR
148.4 ±
3.5 146.3 ±
4.5 0.20 0.08 171.1 ±
6.5 170.3 ±
3.5 0.79
0.01
Average PWR 224.0 ± 36.5 219.1 ± 19.2 0.58 0.05 303.6 ±
59.2 306.1 ± 47.0 0.84
0.01
% VO2max
66.9 ±
7.7
65.8 ±
9.7 0.46 0.11
83.3 ±
5.7
78.8 ± 13.2 0.21
0.21
Time (s)
923.0 ±
118.5 901.5 ± 89.7 0.68
0.03
Note: Data are presented as mean ± standard deviation (SD); N=8; Significance was set at p ≤ 0.05; η2 = effect size, ER =
endurance ride, TT = time trial, Relative performance is expressed per kg, VO2 = oxygen consumption (ml·min-1) or
absolute (L·min-1), PWR = relative power output (W), % VO2Max = avg percentage VO2Max (ml·min-1) or (L·min-1), and ttest = paired comparison.
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Figure Captions
Figure 1. Outline of the experimental approach for the study. RB1 = resting basal blood sample
one, RB2 = resting basal blood sample two, RS1 = resting pre-endurance ride blood sample one,
RS2 = resting pre-endurance ride blood sample two, ER1 = post endurance ride blood sample
one, ER2 = post endurance ride blood sample two, TT1 = post time trial blood sample one, TT2
= post time trial blood sample two.
Figure 2. Cluster plot graph representing the time to finish the time trial portion of the cycle
ergometry test.
Figure 3. Cluster plot graph representing the maximal and average relative power during the
time trial test.
Figure 4. Line graph of the economy at the 30, 60, and 90 minute time points during the
endurance ride with standard deviation bars.
Figure 5. Line graph of the economy at the 5, 10, and 15 minute time points during the time trial
with standard deviation bars.
Figure 6. Line graph of the lactate concentration at the pre-endurance ride, post endurance ride,
and post time trial time points during the cycle ergometry test with standard deviation bars.
Figure 7. Bar graph of the ratio of GSH:GSSG at the specified time points throughout the study
with standard deviation bars.
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Appendix E: Relevant Supplementation Studies
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Study
Abel, 20051

Treatment
High dose (H) and low dose (L) of
arginine (H: 5.7 g·day-1 vs. L: 2.8
g·day-1) and aspartate (H: 8.7
g·day-1 vs. L: 2.2 g·day-1)
α –tocopherol (500 mg·day-1), βcarotene (30 mg·day-1), and
ascorbic acid (1000 mg·day-1) all
taken twice daily

Model/Subjects
30 male trained
cyclists/triathletes

Protocol
4 wks of training with
H (n=10), L (n=10),
or placebo (n=10)

Results
↔ in performance or lactate
concentration in response to
cycling (VO2Max test)

15 trained male
endurance
cyclists/duathlonathletes

↑ % VO2Max at 4mM [lactate]
significantly higher than
training alone in response to
cycling (VO2Max test)

Broad, 200514

carnitine and tartrate
(~3.0 mg·day-1)

15 trained male
endurance athletes

Davison, 200622

ascorbic acid (1000 mg·day-1)

9 male trained
endurance athletes

3 mo of training with
α-tocopherol and βcarotene and 15 days
with ascorbic acid
(crossover design)
4 wks of treatment or
placebo (crossover
design)
2 wks of treatment or
placebo
(crossover design)

Davison, 200723

ascorbic acid (1000 mg·day-1) and
α-tocopherol (400 IU·day-1)

20 male recreational
athletes

↓ cortisol in response to
cycling (2.5 at 60% VO2Max)

Eschbach,
200034

Siberian ginseng (1,200 mg·day-1
standardized extract of ciwujia) α
–tocopherol (60 IU·day-1)

9 male club level
cyclists

4 wks of
treatment(N=10) or
placebo(N=10)
7 d of treatment or
placebo (crossover
design)

Aguilo, 20072

Gomez-Cabrera, Allopurinol (300 mg·day-1)
200346

9 male world-class
cyclists
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3 wks of treatment
(N=4) or placebo
(N=5)

↔substrate oxidation or
cycling performance (90 min
preload + time trial)
↓ cortisol, neutrophilia, and
leukocytosis in response to
cycling (2.5 at 60% VO2Max)

↔ in performance or
substrate utilization in
response to cycling (preload
+ time trial)
↓ lipid peroxidation, ↓ muscle
damage, and ↔ performance
in response to cycling (during
the Tour de France)

Margaritis, 2003 selenium (150 μg·day-1), vitamin
94
A (2000 IU·day-1), ascorbic acid
(120 mg·day-1), α-tocopherol (15
IU·day-1)
McConell,
200699

Arginine infusion (30 g at
0.5g/min) during final 60 min of
cycling

MacRae, 200693

free radical scavenger cocktail
(FRS-Q)* or free radical
scavenger cocktail with quercetin
(FRS)** (600 ml·day-1)
α –tocopherol (800 IU·day-1)

Nieman, 2004108

16 male professional
long-distance
triathletes

2 wks of taper training attenuation of ↓ in reduced
with treatment (N=7) glutathione/oxidized
or placebo (N=9)
glutathione ratio and no
effect on muscle damage in
response to duathlon (running
and cycling test)
9 male endurance
Cycling test with
↑ skeletal muscle glucose
trained athletes
treatment on placebo
clearance with ↔ on
(crossover design)
performance in response to
cycling test (preload + time
trial)
11 male elite cyclists 6 wks of treatment
FRS ↑ performance during a
with FRS or FRS-Q
cycling test (30 km time trial)
(crossover design)
38 world class
triathletes

2 mo of treatment
(N=19) or placebo
(N=17)
4 wk of normal
training and 4 wk
induced over-training
with treatment (n=7)
or placebo (n=10)

Palazzetti,
2004112

selenium (150 μg·day-1), retinyl
acetate (1 mg·day-1), ascorbic acid
(120 mg·day-1), α-tocopherol
(1 mg·day-1)

17 male well-trained
triathletes

Sastre, 1992123

reduced glutathione (1 g·day-1)
and ascorbic acid
(2 g·day-1)

5 male national-level treatment for 7 days
athletes
(crossover design)
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↑ lipid peroxidation and
inflammation in response to
triathlon (World
Championship, HI)
↑ in basal reduced glutathione
level and basal glutathione
peroxidase activity;
attenuated creatine kinase ↑,
and ↑ glutathione peroxidase
activity in response to a
duathlon (running and
cycling test)
attenuation of ↑ in oxidized
glutathione/reduced
glutathione ratio in response
to running (VO2Max test)

Senturk, 2005128

Tessier, 1995133

retinal (50 mg·day-1), ascorbic acid 9 male trained
(1,000 mg·day-1), and αstudents
tocopherol (800 mg·day-1) once
daily
selenium (180 µg)
24 male students

Thomas, 2007134 protein hydrosylate sachet
(2·day-1)†

28 male
trained/recreational
athletes

2 mo of treatment

10 weeks of
endurance training
with treatment (n=12)
or placebo (n=12)
28 days of treatment
or placebo

attenuation of ↑ in red blood
cell lipid peroxidation in
response to cycling (VO2Max
test)
↑ basal plasma glutathione
peroxidase level, ↔ on
physical performance

↑ basal plasma glutathione
peroxidase level and a ↓ in
basal plasma lipid
peroxidation; enhanced
lactate metabolism in
response to cycling (multiple
sprint test)
*Complete list of ingredients in the FRS-Q cocktail (per 300 ml serving): green tea extract (300 mg), ascorbic acid (150 mg), αtocopherol (50 mg), caffeine (45 mg), niacin (25 mg), taurine (9 mg), vitamin B-6 (2.5 mg), vitamin B-2 (2.1 mg), vitamin B-1 (1.9
mg), vitamin B-12 (0.008 mg), and glucose (60 kJ).
**Complete list of ingredients in FRS cocktail (per 300 ml serving): quercetin (300 mg) plus the ingredients in the FRS-Q cocktail.
†Complete list of ingredients in the protein hydrosylate (per sachet): protein (8.3 g), carbohydrate (2.0 g), lipids (0.8 g), sodium (141
mg), potassium (26 mg), calcium (38 mg), magnesium (189 mg), iron (14 mg), zinc (15 mg), copper (2 mg), manganese (3.5 mg),
chromium (25 μg), selenium (75 μg), ascorbic acid (120 mg), α-tocopherol (10 mg), niacin (18 mg), vitamin B12 (1 μg), folic acid
(0.2 mg), thiamin (1.4 mg), riboflavin (1.6 mg), vitamin B6 (2 mg), biotin (0.15 mg), vitamin A (2664 IU), isoleucine (0.55 g), leucine
(1.07 g), lysine (0.80 g), methionine (0.25 g), cystein (0.33 g), phenylalanine (0.36 g), tyrosine (0.35 g), alanine (0.43 g), threonine
(0.47 g), tryptophan (0.19 g), histidine (0.16 g), arginine (0.22 g), aspartic acid (0.99 g), serine (0.36 g), praline (0.45 g), glycine (0.40
g), glutamic acid (1.62 g), valine (0.50 g), essential amino acids (3.74 g), BCAA (2.12 g).
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F.1. Biometrics Data Table
Biometrics
Subject #
Age
(years)
111
44
112
22
114
31
115
22
116
25
117
26
118
29
119
32
Mean
29
Standard Deviation
7.18

Height (cm)

Body Mass (kg)

Body Fat (%)

176.5
171.8
180.5
173.0
182.0
191.0
176.0
174.0
178.1
6.3

73.58
77.81
71.43
85.90
69.51
81.70
72.14
88.17
77.53
7.04

12.86
24.65
19.10
24.70
3.30
12.90
12.42
21.42
16.42
7.38
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F.2. VO2max Testing Data Table
VO2max
Subject #
Relative VO2max
(ml·kg-1·min-1)
111
55.3
112
50.0
114
54.5
115
52.5
116
65.3
117
53.0
118
60.7
119
49.0
Mean
55.0
Standard Deviation
5.5

Absolute VO2max
(L·min-1)
3.889
3.879
3.858
4.714
4.474
4.352
4.321
4.350
4.230
0.320

Relative Max
Power (W·kg)
6.03
4.94
4.90
4.51
6.17
5.33
5.54
4.25
5.21
0.69
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Absolute Max
Power (W)
443.75
384.58
350.00
387.50
429.17
435.42
400.00
375.00
400.68
32.80

Max Heart Rate
(beats·min-1)
189
189
185
198
192
185
180
174
187
7.35

F.3. Performance Data Tables
Table F.3.1. HR Data
HR
Endurance Ride
(beats·min-1)
Subject #
Placebo
Treatment
111
145.78
147.09
112
148.92
148.10
114
145.32
146.78
115
140.26
151.59
116
148.52
147.19
117
148.92
152.86
118
152.98
151.32
119
139.68
142.15
Mean
146.30
148.38
SD
4.50
3.50

Time Trial
Placebo
176.86
173.02
167.32
167.65
172.03
168.34
170.33
166.70
170.28
3.50
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Treatment
169.79
174.86
170.92
184.79
163.00
170.50
167.95
166.86
171.08
6.50

Table F.3.2 Absolute VO2 Data
Absolute
VO2
Endurance Ride
(L·min-1)
Subject #
Placebo
Treatment
111
2.92
2.79
112
2.59
2.69
114
2.70
2.50
115
2.91
3.17
116
1.96
2.20
117
3.02
3.22
118
3.12
3.03
119
2.92
3.00
Mean
2.77
2.83
SD
0.37
0.35

Time Trial
Placebo
3.65
3.10
2.45
3.94
2.44
3.51
3.68
3.88
3.33
0.60
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Treatment
3.35
3.35
2.82
3.89
3.42
3.87
3.64
3.85
3.52
0.37

Table F.3.3. Relative VO2 Data
Relative VO2
Endurance Ride
(ml·kg-1·min-1)
Subject #
Placebo
Treatment
111
39.42
38.15
112
33.61
34.73
114
37.49
35.20
115
33.66
36.93
116
28.26
31.44
117
36.87
39.11
118
42.87
41.76
119
33.50
34.30
Mean
35.71
36.45
SD
4.45
3.22

Time Trial
Placebo
49.27
40.16
34.10
45.67
35.30
42.86
50.82
42.54
42.59
6.01
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Treatment
45.93
43.24
39.71
45.37
48.93
47.05
50.23
42.06
45.32
3.52

Table F.3.4. Absolute Power Data
Absolute
Endurance Ride
Power (W)
Subject #
Placebo
Treatment
111
240
236
112
212
209
114
197
164
115
206
219
116
214
237
117
242
290
118
242
238
119
200
199
Mean
219.13
224.00
SD
19.22
36.53

Time Trial
Placebo
345
277
222
328
267
361
337
312
306.13
46.97
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Treatment
313
293
166
329
326
363
331
308
303.63
59.26

Table F.3.5. Relative Average Power Data
Relative
Power
Endurance Ride
-1
(W·kg )
Subject #
Placebo
Treatment
111
3.26
3.21
112
2.72
2.69
114
2.76
2.30
115
2.40
2.55
116
3.08
3.41
117
2.96
2.80
118
3.35
3.30
119
2.27
2.26
Mean
2.80
2.80
SD
0.40
0.40

Time Trial
Placebo
4.69
3.56
3.12
3.82
3.84
4.42
4.67
3.54
4.00
0.60
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Treatment
4.25
3.77
2.32
3.83
4.69
4.44
4.59
3.49
3.90
0.80

Table F.3.6. RPE
RPE
Subject #
111
112
114
115
116
117
118
119
Mean
SD

Endurance Ride
Placebo
Treatment
13.34
14.20
12.30
12.89
12.41
11.28
11.12
12.17
11.19
12.98
13.03
12.63
13.50
12.81
12.83
13.43
12.47
12.80
0.91
0.86

Placebo
19.35
17.99
12.95
16.87
16.66
17.78
16.58
15.49
16.71
1.91
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Time Trial
Treatment
20.00
16.08
16.72
17.29
15.85
17.48
16.03
17.00
17.06
1.34

Table F.3.7. RER
Respiratory
Exchange
Ratio
Subject #
111
112
114
115
116
117
118
119
Mean
SD

Endurance Ride
Placebo
1.00
0.97
0.93
0.90
0.92
0.90
0.91
0.92
0.93
0.04

Treatment
0.99
0.96
0.98
0.93
0.95
0.92
0.92
0.94
0.95
0.03

Time Trial
Placebo
1.12
1.03
0.94
1.04
1.00
1.00
0.98
1.05
1.02
0.05
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Treatment
1.06
1.05
1.02
1.03
1.01
1.02
0.98
1.05
1.03
0.03

Table F.3.8. Time Trial Time
Time (s)
Time Trial
Subject #
Placebo
Treatment
111
803
888
112
900
852
114
897
1208
115
912
908
116
1102
902
117
854
852
118
906
922
119
838
852
Mean
901.50
923.00
SD
89.72
118.47
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Table F.3.9. Endurance Economy
ER Economy
(W·L-1·min-1)
Subject #
111
112
114
115
116
117
118
119
Mean
SD

Endurance Ride
30-min
Placebo
Treatment
78.91
79.73
74.73
68.32
75.24
62.41
50.54
62.93
104.06
99.10
56.28
51.02
59.15
71.95
57.09
54.39
69.50
68.73
17.48
15.34

60-min
Placebo Treatment
87.32
93.13
85.57
80.73
71.87
67.75
73.11
73.05
122.13
117.85
83.18
77.73
81.83
80.17
75.39
70.30
85.05
82.59
16.05
16.25

90-min
Placebo Treatment
87.96
89.80
87.17
83.75
73.48
70.27
73.87
73.46
117.75
111.36
88.14
81.82
87.86
87.60
75.94
75.57
86.52
84.20
14.26
12.93
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Table F.3.10. Time Trial Economy
TT Economy
(W·L-1·min-1)
5-min
Subject #
Placebo
Treatment
111
98.09
99.76
112
99.65
94.04
114
74.41
67.87
115
91.64
88.48
116
122.18
117.49
117
118.28
100.08
118
99.18
99.34
119
97.37
91.75
Mean
100.10
94.85
SD
14.94
13.95

Time Trial
10-min
Placebo Treatment
93.26
93.45
81.77
82.10
69.09
54.80
74.28
80.67
102.83
88.31
92.96
88.58
88.11
84.86
77.59
79.17
84.99
81.49
11.29
11.77

15-min
Placebo Treatment
91.01
94.06
85.68
83.31
72.93
54.67
84.91
85.13
102.98
91.65
98.01
86.90
90.06
92.08
77.61
80.93
87.90
83.59
9.91
12.56

133

F.4. Lactate Data Table
Lactate
(mmol·L-1)
Pre-ER
Subject #
Placebo
Treatment
111
1.56
0.76
112
0.76
0.75
114
0.79
0.65
115
0.89
0.67
116
0.85
0.60
117
0.80
0.50
118
0.54
0.49
119
0.90
0.78
Mean
0.89
0.65
SD
0.29
0.11

Post-ER
Placebo Treatment
0.83
1.28
0.57
0.85
0.96
1.20
0.62
0.97
0.80
1.20
0.78
1.05
0.72
1.10
1.33
1.63
0.83
1.16
0.24
0.23

Post-TT
Placebo Treatment
6.75
3.44
2.43
3.35
3.37
2.64
6.62
6.91
4.07
3.01
6.50
5.02
5.45
4.76
8.20
6.99
5.42
4.52
1.97
1.71
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F.5. Glucose Data Table
Glucose (mmol·L-1)
Basal
Subject
Placebo
Treatment
#
111
4.21
4.92
112
3.97
4.10
114
5.19
4.35
115
4.62
6.28
116
4.81
4.01
117
4.21
5.00
118
4.43
4.63
119
4.61
4.84
Mean
4.51
4.76
SD
0.39
0.72

Pre-ER

Post-ER

Post-TT

Placebo

Treatment

Placebo

Treatment

Placebo

Treatment

4.47
5.32
5.19
4.78
5.47
4.30
4.44
3.62
4.70
0.62

3.19
4.35
5.44
3.53
3.95
4.10
3.88
4.14
4.07
0.66

5.13
3.03
3.20
3.09
3.55
3.61
3.36
3.52
3.56
0.67

5.30
5.58
4.94
4.89
3.57
5.33
4.51
4.52
4.83
0.64

4.81
3.71
3.71
4.67
5.19
4.85
4.26
7.00
4.78
1.05

4.29
4.08
4.42
5.06
3.90
4.21
3.19
5.21
4.29
0.64
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F.6. Total Body Fuel Oxidation Tables
Table F.6.1 CHO Oxidation
CHO
Endurance Ride
Oxidation
-1
(g·min )
Subject #
Placebo
Treatment
111
4.00
3.72
112
3.22
3.14
114
3.20
2.82
115
2.65
3.30
116
1.98
2.47
117
2.79
3.22
118
2.91
3.01
119
2.93
3.23
Mean
2.96
3.11
SD
0.57
0.37

Time Trial
Placebo
6.97
4.66
2.69
6.18
3.38
4.84
4.64
5.82
4.90
1.42
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Treatment
5.56
5.31
4.15
5.90
4.84
5.70
4.74
5.81
5.25
0.62

Table F.6.2 Fat Oxidation
Fat Oxidation
Endurance Ride
(g·min-1)
Subject #
Placebo
Treatment
111
-0.03
0.01
112
0.10
0.18
114
0.06
0.30
115
0.46
0.35
116
0.24
0.18
117
0.47
0.41
118
0.47
0.39
119
0.37
0.29
Mean
0.27
0.26
SD
0.20
0.13

Time Trial
Placebo
-0.76
-0.19
0.22
-0.33
-0.04
-0.04
0.09
-0.31
-0.17
0.31
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Treatment
-0.39
-0.30
-0.14
-0.25
-0.09
-0.18
0.08
-0.33
-0.20
0.15

F.7. Glutathione Data Tables
Table D.7.1. Resting GSH
Resting total GSH (µmol·L-1)
Basal
Subject #
Placebo
Treatment
111
1075.48
1067.47
112
897.77
859.24
114
1160.01
1204.47
115
847.97
799.11
116
477.78
1020.18
117
1106.66
1078.21
118
1261.41
1138.73
119
1174.25
994.06
Mean
1000.17
1020.19
SD
252.89
135.79

Pre-ER
Placebo
1056.01
834.55
908.83
709.57
399.84
1058.09
868.17
1103.69
867.34
231.17

Treatment
1017.79
729.00
964.60
831.58
893.43
1079.61
1143.04
1174.16
979.15
155.10
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Table F.7.2. Resting GSSG
Resting GSSG (µmol·L-1)
Basal
Subject #
111
112
114
115
116
117
118
119
Mean
SD

Placebo
329.20
264.49
328.48
346.11
252.39
289.81
344.71
277.54
304.09
37.40

Pre-ER
Treatment
265.56
264.87
330.80
479.15
268.67
300.64
305.95
277.92
311.69
71.59

Placebo
384.02
250.61
280.93
312.64
122.63
293.75
284.42
263.21
274.03
73.41

Treatment
270.60
255.20
289.34
409.65
236.36
284.94
321.74
268.86
292.09
53.76
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Table F.7.3. Resting GSH:GSSG
Resting GSH:GSSG
Basal
Subject #
Placebo
Treatment
111
1.27
2.02
112
1.39
1.24
114
1.53
1.64
115
0.45
-0.33
116
-0.11
1.80
117
1.82
1.59
118
1.66
1.72
119
2.23
1.58
Mean
1.28
1.41
SD
0.76
0.74

Pre-Endurance Ride
Placebo
Treatment
0.75
1.76
1.33
0.86
1.24
1.33
0.27
0.03
1.26
1.78
1.60
1.79
1.08
1.55
2.19
2.37
1.22
1.43
0.57
0.71
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Table F.7.4. Exercising GSH
Exercising total GSH (µmol·L-1)
Endurance Ride
Subject #
Placebo
Treatment
111
917.73
968.13
112
781.51
878.82
114
1184.89
1071.69
115
739.37
761.69
116
838.56
987.88
117
1158.05
1086.85
118
1221.92
1014.20
119
927.11
855.31
Mean
971.14
953.07
SD
191.07
112.66

Time Trial
Placebo
Treatment
885.13
980.03
759.15
629.33
1173.67
1059.01
719.82
755.02
798.37
854.48
966.82
929.64
1216.61
1041.00
849.72
839.85
921.16
886.04
185.71
146.81
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Table F.7.5. Exercising GSSG
Exercising GSSG (µmol·L-1)
Endurance Ride
Subject #
Placebo
Treatment
111
350.75
245.81
112
210.02
299.69
114
348.99
311.80
115
318.21
429.67
116
161.54
263.01
117
306.87
285.57
118
377.69
279.67
119
316.60
228.45
Mean
298.83
292.96
SD
74.57
61.65

Time Trial
Placebo
Treatment
437.85
252.53
211.59
231.62
350.16
312.15
337.40
407.88
213.56
249.18
287.76
278.57
396.33
347.86
408.46
258.24
330.39
292.25
86.20
60.13
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Table F.7.6. Exercising GSH:GSSG
Exercising GSH:GSSG
Endurance Ride
Subject #
Placebo
Treatment
111
0.62
1.94
112
1.72
0.93
114
1.40
1.44
115
0.32
-0.23
116
3.19
1.76
117
1.77
1.81
118
1.24
1.63
119
0.93
1.74
Mean
1.40
1.38
SD
0.88
0.72

Time Trial
Placebo
Treatment
0.02
1.88
1.59
0.72
1.35
1.39
0.13
-0.15
1.74
1.43
1.36
1.34
1.06
0.99
0.08
1.25
0.92
1.11
0.72
0.61
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F.8. Nitrotyrosine Data Table
Nitrotyrosine (nmol·L-1)
Pre-ER
Subject #
Placebo
Treatment
111
53.20
40.92
112
1.33
5.63
114
30.16
22.95
115
33.03
44.97
116
47.99
51.65
117
33.86
30.19
118
178.81
211.99
119
5.57
4.89
Mean
47.99
51.65
SD
55.88
67.04

Post-TT
Placebo
53.15
2.83
27.26
38.50
1.34
38.08
424.06
3.84
73.63
142.92

Treatment
43.28
3.06
27.43
55.50
1.03
39.05
352.74
4.31
65.80
117.75
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F.9. Dietary Consumption Data Table
Calories (kcal)
Carbohydrate (g)
Subject
Placebo
Treatment
Placebo
Treatment
#
111
3967.76
3968.76
603.06
603.06
112
2714.89
2762.20
309.64
312.62
114
4337.41
4310.55
437.94
429.33
115
3473.94
3355.32
427.85
456.73
116
5348.31
5310.28
701.37
731.23
117
2413.65
2421.39
288.88
290.22
118
3309.64
3303.37
513.77
503.32
119
1893.26
1824.46
218.57
211.87
Mean
3432.36
3407.04
437.64
442.30
SD
1115.78
1112.24
164.45
171.74
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Fat (g)
Placebo
132.28
104.61
207.37
119.48
199.10
104.47
102.64
75.87
130.73
47.58
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Protein (g)

Treatment
132.28
111.63
194.04
129.16
197.55
97.17
99.43
60.04
127.66
47.62

Placebo
90.41
136.64
198.96
117.88
183.24
70.87
105.49
87.00
123.81
46.27

Treatment
90.41
129.23
219.96
103.07
176.28
105.47
103.09
80.29
125.98
48.10

